seqnames,start,end,width,strand,GERP_score,refsnp_id,ensembl_gene_id,external_gene_name,phenotype_description,name_1006,goslim_goa_description,reactome,biogrid,ensembl_transcript_stable_id,sift_prediction,reg_consequence_types,motif_consequence_types,transcript_tsl,transcript_is_canonical,transcript_appris,ensembl_transcript_chrom_strand,title,ensembl_peptide_allele,motif_name,reg_feature_stable_id,sift_score,consequence_type_tv,Chromosome,Coordinate..GRCm39.,MGI.Gene.ID,Gene.Symbol,Category,Variation.Type,Allele.Summary..all.strains.,C3H.HeJ,FVB.NJ,C57BL.6J,X,BALB.c,BALB.cJ,C3H.He,FVB,C57BL.6,X129S6.SvEvTac
1,120534825,120534825,1,+,-6.86999988555908,rs3676156,ENSMUSG00000058665,En1,"abnormal CNS synaptic transmission|abnormal apical ectodermal ridge morphology|abnormal autopod morphology|abnormal axial skeleton morphology|abnormal axon guidance|abnormal brain commissure morphology|abnormal brain development|abnormal brain morphology|abnormal brain vasculature morphology|abnormal cell cycle|abnormal cell migration|abnormal cerebellar lobule formation|abnormal cerebellum development|abnormal cerebellum morphology|abnormal cerebellum posterior vermis morphology|abnormal cerebellum vermis morphology|abnormal choroid plexus morphology|abnormal corpora quadrigemina morphology|abnormal cranial nerve morphology|abnormal digit morphology|abnormal digit pigmentation|abnormal eccrine sweat gland morphology|abnormal fertility/fecundity|abnormal foot pad morphology|abnormal gait|abnormal hair follicle dermal papilla morphology|abnormal hair follicle development|abnormal hindbrain morphology|abnormal innervation|abnormal limb bone morphology|abnormal limb morphology|abnormal locomotor coordination|abnormal midbrain development|abnormal nail morphology|abnormal neuron differentiation|abnormal neuron morphology|abnormal rib morphology|abnormal serotonergic neuron morphology|abnormal sternebra morphology|abnormal sternum ossification|abnormal suckling behavior|abnormal synapse morphology|absent cerebellar lobules|absent cerebellum|absent inferior colliculus|absent oculomotor nerve|absent trochlear nerve|aphagia|asymmetric sternocostal joints|ataxia|decreased anterior vermis size|decreased body size|decreased dopaminergic neuron number|decreased inferior colliculus size|decreased midbrain size|decreased physiological sensitivity to xenobiotic|decreased rhombomere 1 size|decreased rib number|decreased serotonin level|decreased sternebra size|decreased superior colliculus size|deformed nails|delayed bone ossification|ectopic digits|ectopic dopaminergic neuron|fused phalanges|impaired coordination|increased cell proliferation|increased dopamine level|increased inferior colliculus size|increased locomotor activity|increased superior colliculus size|male infertility|neonatal lethality complete penetrance|no abnormal phenotype detected|perinatal lethality complete penetrance|perinatal lethality incomplete penetrance|polydactyly|postnatal lethality incomplete penetrance|premature death|short sternum|syndactyly|thin apical ectodermal ridge|truncation of digits|wrinkled skin","DNA binding|regulation of DNA-templated transcription|nucleus|multicellular organism development|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of transcription by RNA polymerase II|regulation of gene expression|multicellular organism growth|negative regulation of transcription by RNA polymerase II|limb development|RNA polymerase II cis-regulatory region sequence-specific DNA binding|neuron differentiation|regulation of transcription by RNA polymerase II|membrane|sequence-specific double-stranded DNA binding|DNA-binding transcription repressor activity, RNA polymerase II-specific|dopaminergic neuron differentiation|pigmentation|neuron development|midbrain development|embryonic forelimb morphogenesis|dorsal/ventral pattern formation|embryonic limb morphogenesis|proximal/distal pattern formation|motor learning|cerebellum development|midbrain-hindbrain boundary development|embryonic brain development|adult locomotory behavior|hindbrain development|social behavior|response to cocaine|drinking behavior|negative regulation of neuron apoptotic process|negative regulation of neuron death","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|anatomical structure development|transcription regulator activity|cell differentiation|nervous system process|programmed cell death","",199444,ENSMUST00000079721,"",regulatory_region_variant,"",tsl1 (assigned to previous version 8),1,principal1,1,"",T,"",ENSMUSR00000486986,"",synonymous_variant,1,120534825,MGI:95389,En1,within coordinates of,SNP,A/C,A,A,C,,"","","","","",
1,132358480,132358480,1,+,-7.30000019073486,rs32435023,ENSMUSG00000042046,Dstyk,impaired spatial learning,"ATP binding|protein phosphorylation|protein kinase activity|negative regulation of apoptotic process|cytoplasm|membrane|transferase activity|plasma membrane|nucleotide binding|basolateral plasma membrane|apical plasma membrane|kinase activity|phosphorylation|anchoring junction|protein serine/threonine kinase activity|protein tyrosine kinase activity|peptidyl-tyrosine phosphorylation|protein serine kinase activity|positive regulation of ERK1 and ERK2 cascade|cellular response to fibroblast growth factor stimulus|protein serine/threonine/tyrosine kinase activity|positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of kinase activity","protein modification process|catalytic activity|transferase activity|catalytic activity, acting on a protein|programmed cell death|plasma membrane|signaling","",229434,ENSMUST00000045110,"",regulatory_region_variant,"",tsl1 (assigned to previous version 13),1,principal1,1,"","","",ENSMUSR00000770315,"","intron_variant|non_coding_transcript_variant",1,132358480,MGI:1925064,Dstyk,within coordinates of,SNP,C/G,C,C,G,,"","","","","",""
1,132359686,132359686,1,+,-6.40000009536743,rs32599068,ENSMUSG00000042046,Dstyk,impaired spatial learning,"ATP binding|protein phosphorylation|protein kinase activity|negative regulation of apoptotic process|cytoplasm|membrane|transferase activity|plasma membrane|nucleotide binding|basolateral plasma membrane|apical plasma membrane|kinase activity|phosphorylation|anchoring junction|protein serine/threonine kinase activity|protein tyrosine kinase activity|peptidyl-tyrosine phosphorylation|protein serine kinase activity|positive regulation of ERK1 and ERK2 cascade|cellular response to fibroblast growth factor stimulus|protein serine/threonine/tyrosine kinase activity|positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of kinase activity","protein modification process|catalytic activity|transferase activity|catalytic activity, acting on a protein|programmed cell death|plasma membrane|signaling","",229434,ENSMUST00000045110,"",regulatory_region_variant,"",tsl1 (assigned to previous version 13),1,principal1,1,"","","",ENSMUSR00000770315,"","intron_variant|non_coding_transcript_variant",1,132359686,MGI:1925064,Dstyk,within coordinates of,SNP,C/T,T,T,C,,"","","","","",""
1,132359778,132359778,1,+,-5.8899998664856,rs32495217,ENSMUSG00000042046,Dstyk,impaired spatial learning,"ATP binding|protein phosphorylation|protein kinase activity|negative regulation of apoptotic process|cytoplasm|membrane|transferase activity|plasma membrane|nucleotide binding|basolateral plasma membrane|apical plasma membrane|kinase activity|phosphorylation|anchoring junction|protein serine/threonine kinase activity|protein tyrosine kinase activity|peptidyl-tyrosine phosphorylation|protein serine kinase activity|positive regulation of ERK1 and ERK2 cascade|cellular response to fibroblast growth factor stimulus|protein serine/threonine/tyrosine kinase activity|positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of kinase activity","protein modification process|catalytic activity|transferase activity|catalytic activity, acting on a protein|programmed cell death|plasma membrane|signaling","",229434,ENSMUST00000045110,"",regulatory_region_variant,"",tsl1 (assigned to previous version 13),1,principal1,1,"","","",ENSMUSR00000770315,"","intron_variant|non_coding_transcript_variant",1,132359778,MGI:1925064,Dstyk,within coordinates of,SNP,A/G,G,G,A,,"","","","","",""
1,163112831,163112831,1,+,-6.76999998092651,rs31360561,ENSMUSG00000026586,Prrx1,"abnormal Meckel's cartilage morphology|abnormal aortic arch morphology|abnormal artery morphology|abnormal cartilage morphology|abnormal cranium morphology|abnormal fetal ductus arteriosus morphology|abnormal forelimb zeugopod morphology|abnormal hindlimb zeugopod morphology|abnormal incudostapedial joint morphology|abnormal incus morphology|abnormal long bone hypertrophic chondrocyte zone|abnormal long bone morphology|abnormal lung vasculature morphology|abnormal malleus manubrium morphology|abnormal malleus morphology|abnormal malleus processus brevis morphology|abnormal mandible morphology|abnormal metacarpal bone morphology|abnormal middle ear ossicle morphology|abnormal palatal shelf fusion at midline|abnormal pulmonary trunk morphology|abnormal respiration|abnormal stapes crus morpholgy|abnormal stapes morphology|abnormal stylohyoid ligament morphology|abnormal thoracic vertebrae morphology|abnormal tibia morphology|abnormal trabecular bone morphology|abnormal vertebrae morphology|absent alisphenoid bone|absent gonial bone|absent maxillary shelf|absent palatine bone horizontal plate|absent stapes obturator foramen|absent supraoccipital bone|absent temporal bone squamous part|absent temporomandibular joint|absent tympanic ring|absent zygomatic bone|alisphenoid bone hypoplasia|aphagia|bowed radius|bowed tibia|cleft secondary palate|cyanosis|decreased body size|decreased width of hypertrophic chondrocyte zone|delayed bone ossification|distended abdomen|long limbs|lowered ear position|mandible hypoplasia|maxillary shelf hypoplasia|microcephaly|neonatal lethality|neonatal lethality complete penetrance|pointed snout|pterygoid bone hypoplasia|pulmonary hypoplasia|respiratory distress|short fibula|short limbs|short malleus manubrium|short radius|short tibia|short ulna|small otic capsule|spina bifida","DNA binding|regulation of DNA-templated transcription|DNA-binding transcription factor activity, RNA polymerase II-specific|nucleus|positive regulation of transcription by RNA polymerase II|positive regulation of stem cell proliferation|negative regulation of transcription by RNA polymerase II|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cytosol|stem cell proliferation|cartilage development|embryonic cranial skeleton morphogenesis|nucleoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription activator activity, RNA polymerase II-specific|inner ear morphogenesis|roof of mouth development|transcription by RNA polymerase II|RNA polymerase II general transcription initiation factor activity|RNA polymerase II-specific DNA-binding transcription factor binding|smoothened signaling pathway|DNA-binding transcription repressor activity, RNA polymerase II-specific|artery morphogenesis|positive regulation of smoothened signaling pathway|embryonic skeletal system morphogenesis|HMG box domain binding|embryonic limb morphogenesis|middle ear morphogenesis|neuronal stem cell population maintenance|positive regulation of mesenchymal cell proliferation|neuron fate determination|mesenchymal cell proliferation|regulation of neuron projection regeneration","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus|cytosol|anatomical structure development|nucleoplasm|general transcription initiation factor activity|signaling|cell differentiation","",202269,"ENSMUST00000027878|ENSMUST00000075805|ENSMUST00000174098|ENSMUST00000174397|ENSMUST00000183691","",regulatory_region_variant,"","tsl1 (assigned to previous version 13)|tsl1 (assigned to previous version 12)|tsl1 (assigned to previous version 1)|tsl1 (assigned to previous version 2)",1,"principal1|",-1,"","","",ENSMUSR00000303625,"","intron_variant|non_coding_transcript_variant",1,163112831,MGI:97712,Prrx1,within coordinates of,SNP,G/T,G,T,T,,"","","","","",
1,176798655,176798655,1,+,-5.17999982833862,rs6184878,ENSMUSG00000026504|ENSMUSG00000103251,Sdccag8|Gm37519,"abnormal DNA replication|abnormal choroid plexus morphology|abnormal electroretinogram waveform feature|abnormal kidney corticomedullary boundary morphology|abnormal kidney morphology|abnormal neuronal migration|abnormal nonmotile primary cilium morphology|abnormal retina photoreceptor morphology|blindness|cleft palate|decreased retina cone cell number|dilated renal tubule|enlarged kidney|enlarged lateral ventricles|kidney cortex cyst|kidney corticomedullary cyst|kidney cyst|photoreceptor inner segment degeneration|photoreceptor outer segment degeneration|polydactyly|postnatal lethality incomplete penetrance|renal glomerulus cyst|renal interstitial fibrosis|retina degeneration|retina outer nuclear layer degeneration|retina photoreceptor degeneration"|"","centrosome|centrosome cycle|protein binding|cytoplasm|microtubule organizing center|cell projection organization|cytoskeleton|cell projection|cell-cell junction|centriolar satellite|anchoring junction|centriole|neuron migration|establishment of cell polarity|ciliary basal body|regulation of cilium assembly|tube formation|photoreceptor cell cilium|microtubule organizing center organization"|"","organelle|cytoskeleton|microtubule organizing center|cytoskeleton organization|anatomical structure development|cell differentiation|cell motility|establishment or maintenance of cell polarity|cilium|cilium organization"|"","|R-MMU-1640170|R-MMU-68886|R-MMU-69278|R-MMU-453274|R-MMU-69275|R-MMU-1852241|R-MMU-5617833|R-MMU-2565942|R-MMU-380259|R-MMU-380270|R-MMU-380284|R-MMU-380287|R-MMU-380320|R-MMU-5620912|R-MMU-68877|R-MMU-8854518"|"",218334|"",ENSMUST00000027785|"","",regulatory_region_variant|"",TF_binding_site_variant|"",tsl1 (assigned to previous version 14)|"",1|"",principal1|"",1,"","",ENSPFM0035,ENSMUSR00000018166,"","intron_variant|NMD_transcript_variant"|upstream_gene_variant,1,176798655,MGI:1924066,Sdccag8,within coordinates of,SNP,G/T,T,T,G,,"","","","","",""
1,176798702,176798702,1,+,-7.23999977111816,rs6185360,ENSMUSG00000026504|ENSMUSG00000103251,Sdccag8|Gm37519,"abnormal DNA replication|abnormal choroid plexus morphology|abnormal electroretinogram waveform feature|abnormal kidney corticomedullary boundary morphology|abnormal kidney morphology|abnormal neuronal migration|abnormal nonmotile primary cilium morphology|abnormal retina photoreceptor morphology|blindness|cleft palate|decreased retina cone cell number|dilated renal tubule|enlarged kidney|enlarged lateral ventricles|kidney cortex cyst|kidney corticomedullary cyst|kidney cyst|photoreceptor inner segment degeneration|photoreceptor outer segment degeneration|polydactyly|postnatal lethality incomplete penetrance|renal glomerulus cyst|renal interstitial fibrosis|retina degeneration|retina outer nuclear layer degeneration|retina photoreceptor degeneration"|"","centrosome|centrosome cycle|protein binding|cytoplasm|microtubule organizing center|cell projection organization|cytoskeleton|cell projection|cell-cell junction|centriolar satellite|anchoring junction|centriole|neuron migration|establishment of cell polarity|ciliary basal body|regulation of cilium assembly|tube formation|photoreceptor cell cilium|microtubule organizing center organization"|"","organelle|cytoskeleton|microtubule organizing center|cytoskeleton organization|anatomical structure development|cell differentiation|cell motility|establishment or maintenance of cell polarity|cilium|cilium organization"|"","|R-MMU-1640170|R-MMU-68886|R-MMU-69278|R-MMU-453274|R-MMU-69275|R-MMU-1852241|R-MMU-5617833|R-MMU-2565942|R-MMU-380259|R-MMU-380270|R-MMU-380284|R-MMU-380287|R-MMU-380320|R-MMU-5620912|R-MMU-68877|R-MMU-8854518"|"",218334|"",ENSMUST00000027785|"","",regulatory_region_variant|"","",tsl1 (assigned to previous version 14)|"",1|"",principal1|"",1,"","","",ENSMUSR00000018166,"","intron_variant|NMD_transcript_variant"|upstream_gene_variant,1,176798702,MGI:1924066,Sdccag8,within coordinates of,SNP,A/G,G,G,A,,"","","","","",""
1,176814951,176814951,1,+,-5.15000009536743,rs30470205,ENSMUSG00000026504,Sdccag8,"abnormal DNA replication|abnormal choroid plexus morphology|abnormal electroretinogram waveform feature|abnormal kidney corticomedullary boundary morphology|abnormal kidney morphology|abnormal neuronal migration|abnormal nonmotile primary cilium morphology|abnormal retina photoreceptor morphology|blindness|cleft palate|decreased retina cone cell number|dilated renal tubule|enlarged kidney|enlarged lateral ventricles|kidney cortex cyst|kidney corticomedullary cyst|kidney cyst|photoreceptor inner segment degeneration|photoreceptor outer segment degeneration|polydactyly|postnatal lethality incomplete penetrance|renal glomerulus cyst|renal interstitial fibrosis|retina degeneration|retina outer nuclear layer degeneration|retina photoreceptor degeneration","centrosome|centrosome cycle|protein binding|cytoplasm|microtubule organizing center|cell projection organization|cytoskeleton|cell projection|cell-cell junction|centriolar satellite|anchoring junction|centriole|neuron migration|establishment of cell polarity|ciliary basal body|regulation of cilium assembly|tube formation|photoreceptor cell cilium|microtubule organizing center organization","organelle|cytoskeleton|microtubule organizing center|cytoskeleton organization|anatomical structure development|cell differentiation|cell motility|establishment or maintenance of cell polarity|cilium|cilium organization","|R-MMU-1640170|R-MMU-68886|R-MMU-69278|R-MMU-453274|R-MMU-69275|R-MMU-1852241|R-MMU-5617833|R-MMU-2565942|R-MMU-380259|R-MMU-380270|R-MMU-380284|R-MMU-380287|R-MMU-380320|R-MMU-5620912|R-MMU-68877|R-MMU-8854518",218334,ENSMUST00000027785,"",regulatory_region_variant,TF_binding_site_variant,tsl1 (assigned to previous version 14),1,principal1,1,"","",ENSPFM0018,ENSMUSR00000772431,"","intron_variant|NMD_transcript_variant",1,176814951,MGI:1924066,Sdccag8,within coordinates of,SNP,C/T,C,T,T,,"","","","","",""
1,176815568,176815568,1,+,-5.19000005722046,rs31763336,ENSMUSG00000026504,Sdccag8,"abnormal DNA replication|abnormal choroid plexus morphology|abnormal electroretinogram waveform feature|abnormal kidney corticomedullary boundary morphology|abnormal kidney morphology|abnormal neuronal migration|abnormal nonmotile primary cilium morphology|abnormal retina photoreceptor morphology|blindness|cleft palate|decreased retina cone cell number|dilated renal tubule|enlarged kidney|enlarged lateral ventricles|kidney cortex cyst|kidney corticomedullary cyst|kidney cyst|photoreceptor inner segment degeneration|photoreceptor outer segment degeneration|polydactyly|postnatal lethality incomplete penetrance|renal glomerulus cyst|renal interstitial fibrosis|retina degeneration|retina outer nuclear layer degeneration|retina photoreceptor degeneration","centrosome|centrosome cycle|protein binding|cytoplasm|microtubule organizing center|cell projection organization|cytoskeleton|cell projection|cell-cell junction|centriolar satellite|anchoring junction|centriole|neuron migration|establishment of cell polarity|ciliary basal body|regulation of cilium assembly|tube formation|photoreceptor cell cilium|microtubule organizing center organization","organelle|cytoskeleton|microtubule organizing center|cytoskeleton organization|anatomical structure development|cell differentiation|cell motility|establishment or maintenance of cell polarity|cilium|cilium organization","|R-MMU-1640170|R-MMU-68886|R-MMU-69278|R-MMU-453274|R-MMU-69275|R-MMU-1852241|R-MMU-5617833|R-MMU-2565942|R-MMU-380259|R-MMU-380270|R-MMU-380284|R-MMU-380287|R-MMU-380320|R-MMU-5620912|R-MMU-68877|R-MMU-8854518",218334,ENSMUST00000027785,"",regulatory_region_variant,"",tsl1 (assigned to previous version 14),1,principal1,1,"","","",ENSMUSR00000772431,"","intron_variant|NMD_transcript_variant",1,176815568,MGI:1924066,Sdccag8,within coordinates of,SNP,C/T,C,T,T,,"","","","","",""
1,64134085,64134085,1,+,-5.55999994277954,rs3158980,ENSMUSG00000025959,Klf7,"abnormal vertebrae morphology|decreased circulating serum albumin level|hyperactivity|impaired righting response|increased circulating aspartate transaminase level|increased mean platelet volume|persistence of hyaloid vascular system|preweaning lethality complete penetrance|abnormal axon extension|abnormal axon guidance|abnormal brain morphology|abnormal cerebral cortex morphology|abnormal corpus callosum morphology|abnormal dentate gyrus morphology|abnormal hippocampal fimbria morphology|abnormal hippocampus pyramidal cell morphology|abnormal nervous system tract morphology|abnormal olfactory nerve morphology|abnormal olfactory neuron innervation pattern|abnormal sensory neuron innervation pattern|abnormal telencephalon morphology|absent anterior commissure|absent gastric milk in neonates|cyanosis|hypopnea|postnatal lethality complete penetrance|small olfactory bulb|unresponsive to tactile stimuli","nucleus|positive regulation of transcription by RNA polymerase II|negative regulation of transcription by RNA polymerase II|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cytosol|nucleoplasm|DNA binding|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|DNA-binding transcription factor activity|protein binding|positive regulation of DNA-templated transcription|DNA-binding transcription activator activity, RNA polymerase II-specific|glucose homeostasis|dendrite morphogenesis|axonogenesis|negative regulation of insulin secretion involved in cellular response to glucose stimulus|axon guidance|regulation of epidermal cell differentiation|negative regulation of adipose tissue development","organelle|nucleus|DNA-templated transcription|regulation of DNA-templated transcription|DNA binding|cytosol|nucleoplasm|transcription regulator activity|anatomical structure development|cell differentiation|signaling","","","ENSMUST00000055001|ENSMUST00000114086","",regulatory_region_variant,"","tsl1 (assigned to previous version 9)|tsl1 (assigned to previous version 7)",1,"|principal1",-1,"","","",ENSMUSR00000767612,"",intron_variant,1,64134085,MGI:1935151,Klf7,within coordinates of,SNP,C/T,C,C,T,,"","","","","",
1,91963610,91963610,1,+,-6.61999988555908,rs13475981,ENSMUSG00000026313,Hdac4,"abnormal behavior|increased NK cell number|increased circulating alkaline phosphatase level|no spontaneous movement|abnormal bone ossification|abnormal costal cartilage morphology|abnormal eating behavior|abnormal food preference|abnormal involuntary movement|abnormal long bone hypertrophic chondrocyte zone|abnormal operant conditioning behavior|abnormal spike wave discharge|abnormal vertebrae morphology|convulsive seizures|decreased aggression towards mice|decreased body size|decreased body weight|decreased food intake|decreased locomotor activity|decreased susceptibility to weight gain|decreased vertical activity|domed cranium|environmentally induced seizures|exencephaly|increased anxiety-related response|increased blinking frequency|increased coping response|increased food intake|increased grooming behavior|increased locomotor activity|increased susceptibility to weight gain|increased thermal nociceptive threshold|postnatal lethality complete penetrance|premature endochondral bone ossification|premature lambdoid suture closure|tonic seizures","histone deacetylase activity|histone deacetylation|chromatin organization|histone deacetylase complex|nucleus|sequence-specific DNA binding|negative regulation of osteoblast differentiation|nuclear speck|epigenetic regulation of gene expression|protein binding|positive regulation of transcription by RNA polymerase II|positive regulation of cell population proliferation|negative regulation of glycolytic process|negative regulation of transcription by RNA polymerase II|negative regulation of cell population proliferation|RNA polymerase II cis-regulatory region sequence-specific DNA binding|chromatin binding|cytosol|osteoblast differentiation|cytoplasm|skeletal system development|cell population proliferation|transcription cis-regulatory region binding|regulation of protein binding|nucleoplasm|metal ion binding|hydrolase activity|protein-containing complex|positive regulation of neuron apoptotic process|regulation of multicellular organismal process|response to stimulus|DNA binding|identical protein binding|protein sumoylation|response to xenobiotic stimulus|zinc ion binding|chromatin remodeling|negative regulation of DNA-templated transcription|DNA-binding transcription factor binding|Z disc|neuromuscular junction|RNA polymerase II-specific DNA-binding transcription factor binding|negative regulation of DNA-binding transcription factor activity|positive regulation of DNA-binding transcription factor activity|histone deacetylase binding|transcription corepressor activity|sarcomere|positive regulation of lamellipodium assembly|promoter-specific chromatin binding|protein kinase binding|A band|transcription repressor complex|response to interleukin-1|positive regulation of smooth muscle cell migration|positive regulation of smooth muscle cell proliferation|regulation of cardiac muscle contraction by calcium ion signaling|protein lysine deacetylase activity|protein deacetylation|histone H3 deacetylation|histone H4 deacetylation|actomyosin|positive regulation of DNA-templated transcription|SUMO transferase activity|positive regulation of protein sumoylation|potassium ion binding|osteoblast development|positive regulation of reactive oxygen species biosynthetic process|negative regulation of myotube differentiation|negative regulation of miRNA transcription|response to denervation involved in regulation of muscle adaptation|peptidyl-lysine deacetylation|regulation of skeletal muscle fiber development|cellular response to mechanical stimulus|cellular response to tumor necrosis factor|cellular response to parathyroid hormone stimulus|positive regulation of male mating behavior|regulation of skeletal muscle fiber differentiation|histone modification","catalytic activity|hydrolase activity|catalytic activity, acting on a protein|protein modification process|chromatin organization|organelle|nucleus|nucleoplasm|DNA binding|cell differentiation|DNA-templated transcription|regulation of DNA-templated transcription|carbohydrate metabolic process|generation of precursor metabolites and energy|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|cytosol|anatomical structure development|programmed cell death|transcription regulator activity|cell motility|signaling|muscle system process|circulatory system process|cytoskeleton|transferase activity|reproductive process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-4551638|R-MMU-597592|R-MMU-350054|R-MMU-8878159|R-MMU-8951936|R-MMU-4090294|",229009,"ENSMUST00000008995|ENSMUST00000097644","",regulatory_region_variant,"","tsl1 (assigned to previous version 14)|tsl1 (assigned to previous version 8)",1,principal1,-1,"","","",ENSMUSR00000769217,"","intron_variant|non_coding_transcript_variant",1,91963610,MGI:3036234,Hdac4,within coordinates of,SNP,C/T,C,T,T,,"","","","","",
10,68092053,68092053,1,+,-7.09000015258789,rs29324889,ENSMUSG00000019947,Arid5b,"abnormal adipose tissue morphology|abnormal adrenal gland zona reticularis morphology|abnormal cell migration|abnormal endochondral bone ossification|abnormal fat cell morphology|abnormal female reproductive system morphology|abnormal fertility/fecundity|abnormal frontal bone morphology|abnormal immune system organ morphology|abnormal kidney morphology|abnormal kidney physiology|abnormal long bone epiphyseal plate morphology|abnormal long bone hypertrophic chondrocyte zone|abnormal lymphopoiesis|abnormal male reproductive system morphology|abnormal mating frequency|abnormal mating receptivity|abnormal neurocranium morphology|abnormal ovary morphology|abnormal palate morphology|abnormal renal glomerulus morphology|abnormal skeleton morphology|abnormal smooth muscle morphology|abnormal sternum morphology|abnormal vertebrae morphology|abnormal vertebral arch morphology|absent corpus luteum|absent mature ovarian follicles|arrest of spermatogenesis|asymmetric sternocostal joints|bilateral cryptorchism|broad snout|cryptorchism|decreased body length|decreased body size|decreased body weight|decreased bone marrow cell number|decreased brown adipose tissue amount|decreased brown fat lipid droplet number|decreased double-positive T cell number|decreased fibroblast cell migration|decreased food intake|decreased palatine bone horizontal plate size|decreased percent body fat/body weight|decreased pro-B cell number|decreased susceptibility to diet-induced obesity|decreased white adipose tissue amount|female infertility|increased blood urea nitrogen level|increased food intake|increased single-positive T cell number|kidney inflammation|neonatal lethality incomplete penetrance|pale kidney|perinatal lethality incomplete penetrance|poor grooming|postnatal growth retardation|postnatal lethality|reduced male fertility|seminiferous tubule degeneration|short maxilla|short nasal bone|short premaxilla|short snout|short tibia|slow postnatal weight gain|small endometrial glands|small kidney|small presphenoid bone|small testis|small uterus|spleen hypoplasia|thymus cortex hypoplasia|thymus hypoplasia|unilateral cryptorchism","DNA binding|nucleus|transcription coactivator activity|positive regulation of DNA-binding transcription factor activity|adipose tissue development|cellular response to leukemia inhibitory factor|post-embryonic development|multicellular organism growth|negative regulation of transcription by RNA polymerase II|platelet-derived growth factor receptor signaling pathway|transcription cis-regulatory region binding|regulation of transcription by RNA polymerase II|kidney development|nitrogen compound metabolic process|skeletal system morphogenesis|roof of mouth development|face morphogenesis|positive regulation of DNA-templated transcription|fibroblast migration|fat cell differentiation|cell development|male gonad development|female gonad development|adrenal gland development|muscle organ morphogenesis|fat pad development","DNA binding|organelle|nucleus|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|anatomical structure development|signaling|cell motility|cell differentiation|reproductive process","R-MMU-3247509|R-MMU-4839726|R-MMU-3214842|",214670,"ENSMUST00000020106|ENSMUST00000218425|ENSMUST00000219238","",regulatory_region_variant,"","tsl1 (assigned to previous version 8)|tsl1 (assigned to previous version 1)",1,"|principal4",-1,"","","",ENSMUSR00000028519,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant",10,68092053,MGI:2175912,Arid5b,within coordinates of,SNP,A/C,C,C,A,,"","","","","",
10,68092528,68092528,1,+,-6.30999994277954,rs29346158,ENSMUSG00000019947,Arid5b,"abnormal adipose tissue morphology|abnormal adrenal gland zona reticularis morphology|abnormal cell migration|abnormal endochondral bone ossification|abnormal fat cell morphology|abnormal female reproductive system morphology|abnormal fertility/fecundity|abnormal frontal bone morphology|abnormal immune system organ morphology|abnormal kidney morphology|abnormal kidney physiology|abnormal long bone epiphyseal plate morphology|abnormal long bone hypertrophic chondrocyte zone|abnormal lymphopoiesis|abnormal male reproductive system morphology|abnormal mating frequency|abnormal mating receptivity|abnormal neurocranium morphology|abnormal ovary morphology|abnormal palate morphology|abnormal renal glomerulus morphology|abnormal skeleton morphology|abnormal smooth muscle morphology|abnormal sternum morphology|abnormal vertebrae morphology|abnormal vertebral arch morphology|absent corpus luteum|absent mature ovarian follicles|arrest of spermatogenesis|asymmetric sternocostal joints|bilateral cryptorchism|broad snout|cryptorchism|decreased body length|decreased body size|decreased body weight|decreased bone marrow cell number|decreased brown adipose tissue amount|decreased brown fat lipid droplet number|decreased double-positive T cell number|decreased fibroblast cell migration|decreased food intake|decreased palatine bone horizontal plate size|decreased percent body fat/body weight|decreased pro-B cell number|decreased susceptibility to diet-induced obesity|decreased white adipose tissue amount|female infertility|increased blood urea nitrogen level|increased food intake|increased single-positive T cell number|kidney inflammation|neonatal lethality incomplete penetrance|pale kidney|perinatal lethality incomplete penetrance|poor grooming|postnatal growth retardation|postnatal lethality|reduced male fertility|seminiferous tubule degeneration|short maxilla|short nasal bone|short premaxilla|short snout|short tibia|slow postnatal weight gain|small endometrial glands|small kidney|small presphenoid bone|small testis|small uterus|spleen hypoplasia|thymus cortex hypoplasia|thymus hypoplasia|unilateral cryptorchism","DNA binding|nucleus|transcription coactivator activity|positive regulation of DNA-binding transcription factor activity|adipose tissue development|cellular response to leukemia inhibitory factor|post-embryonic development|multicellular organism growth|negative regulation of transcription by RNA polymerase II|platelet-derived growth factor receptor signaling pathway|transcription cis-regulatory region binding|regulation of transcription by RNA polymerase II|kidney development|nitrogen compound metabolic process|skeletal system morphogenesis|roof of mouth development|face morphogenesis|positive regulation of DNA-templated transcription|fibroblast migration|fat cell differentiation|cell development|male gonad development|female gonad development|adrenal gland development|muscle organ morphogenesis|fat pad development","DNA binding|organelle|nucleus|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|anatomical structure development|signaling|cell motility|cell differentiation|reproductive process","R-MMU-3247509|R-MMU-4839726|R-MMU-3214842|",214670,"ENSMUST00000020106|ENSMUST00000218425|ENSMUST00000219238","",regulatory_region_variant,"","tsl1 (assigned to previous version 8)|tsl1 (assigned to previous version 1)",1,"|principal4",-1,"","","",ENSMUSR00000028519,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant",10,68092528,MGI:2175912,Arid5b,within coordinates of,SNP,C/T,C,C,T,,"","","","","",
10,68097944,68097944,1,+,-5.73000001907349,rs29374410,ENSMUSG00000019947,Arid5b,"abnormal adipose tissue morphology|abnormal adrenal gland zona reticularis morphology|abnormal cell migration|abnormal endochondral bone ossification|abnormal fat cell morphology|abnormal female reproductive system morphology|abnormal fertility/fecundity|abnormal frontal bone morphology|abnormal immune system organ morphology|abnormal kidney morphology|abnormal kidney physiology|abnormal long bone epiphyseal plate morphology|abnormal long bone hypertrophic chondrocyte zone|abnormal lymphopoiesis|abnormal male reproductive system morphology|abnormal mating frequency|abnormal mating receptivity|abnormal neurocranium morphology|abnormal ovary morphology|abnormal palate morphology|abnormal renal glomerulus morphology|abnormal skeleton morphology|abnormal smooth muscle morphology|abnormal sternum morphology|abnormal vertebrae morphology|abnormal vertebral arch morphology|absent corpus luteum|absent mature ovarian follicles|arrest of spermatogenesis|asymmetric sternocostal joints|bilateral cryptorchism|broad snout|cryptorchism|decreased body length|decreased body size|decreased body weight|decreased bone marrow cell number|decreased brown adipose tissue amount|decreased brown fat lipid droplet number|decreased double-positive T cell number|decreased fibroblast cell migration|decreased food intake|decreased palatine bone horizontal plate size|decreased percent body fat/body weight|decreased pro-B cell number|decreased susceptibility to diet-induced obesity|decreased white adipose tissue amount|female infertility|increased blood urea nitrogen level|increased food intake|increased single-positive T cell number|kidney inflammation|neonatal lethality incomplete penetrance|pale kidney|perinatal lethality incomplete penetrance|poor grooming|postnatal growth retardation|postnatal lethality|reduced male fertility|seminiferous tubule degeneration|short maxilla|short nasal bone|short premaxilla|short snout|short tibia|slow postnatal weight gain|small endometrial glands|small kidney|small presphenoid bone|small testis|small uterus|spleen hypoplasia|thymus cortex hypoplasia|thymus hypoplasia|unilateral cryptorchism","DNA binding|nucleus|transcription coactivator activity|positive regulation of DNA-binding transcription factor activity|adipose tissue development|cellular response to leukemia inhibitory factor|post-embryonic development|multicellular organism growth|negative regulation of transcription by RNA polymerase II|platelet-derived growth factor receptor signaling pathway|transcription cis-regulatory region binding|regulation of transcription by RNA polymerase II|kidney development|nitrogen compound metabolic process|skeletal system morphogenesis|roof of mouth development|face morphogenesis|positive regulation of DNA-templated transcription|fibroblast migration|fat cell differentiation|cell development|male gonad development|female gonad development|adrenal gland development|muscle organ morphogenesis|fat pad development","DNA binding|organelle|nucleus|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|anatomical structure development|signaling|cell motility|cell differentiation|reproductive process","R-MMU-3247509|R-MMU-4839726|R-MMU-3214842|",214670,"ENSMUST00000020106|ENSMUST00000218425|ENSMUST00000219238","",regulatory_region_variant,"","tsl1 (assigned to previous version 8)|tsl1 (assigned to previous version 1)",1,"|principal4",-1,"","","",ENSMUSR00000311009,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant",10,68097944,MGI:2175912,Arid5b,within coordinates of,SNP,A/G,A,A,G,,"","","","","",
10,93122981,93122981,1,+,-7.57999992370606,rs29327285,ENSMUSG00000008398,Elk3,"abnormal eye morphology|abnormal retina blood vessel pattern|abnormal retina vasculature morphology|decreased prepulse inhibition|increased circulating HDL cholesterol level|increased circulating alkaline phosphatase level|increased circulating cholesterol level|abnormal blood vessel physiology|abnormal cardiovascular system physiology|abnormal pleura morphology|abnormal retina blood vessel morphology|abnormal vascular endothelial cell morphology|chylothorax|decreased angiogenesis|decreased locomotor activity|lymphangiectasis|postnatal lethality incomplete penetrance|premature death|respiratory distress|respiratory failure","regulation of DNA-templated transcription|DNA-binding transcription factor activity|sequence-specific DNA binding|regulation of transcription by RNA polymerase II|mitochondrion|nucleus|positive regulation of transcription by RNA polymerase II|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|nucleoplasm|DNA binding|negative regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|DNA-binding transcription activator activity, RNA polymerase II-specific|cell differentiation|negative regulation of DNA-templated transcription|sequence-specific double-stranded DNA binding|DNA-binding transcription repressor activity, RNA polymerase II-specific|wound healing|purine-rich negative regulatory element binding","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|DNA binding|organelle|mitochondrion|nucleus|anatomical structure development|nucleoplasm|cell differentiation|wound healing","",199430,"ENSMUST00000008542|ENSMUST00000151153","",regulatory_region_variant,"","tsl1 (assigned to previous version 11)|tsl1 (assigned to previous version 1)",1,"principal1|",-1,"","","",ENSMUSR00000777610,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant",10,93122981,MGI:101762,Elk3,within coordinates of,SNP,A/C,A,A,C,,"","","","","",
11,59220041,59220041,1,+,-5.05000019073486,rs6245211,ENSMUSG00000000126,Wnt9a,"abnormal basioccipital bone morphology|abnormal cervical atlas morphology|abnormal chondrocyte physiology|abnormal cranium morphology|abnormal frontal bone morphology|abnormal interfrontal bone morphology|abnormal joint morphology|abnormal sagittal suture morphology|abnormal skeleton development|abnormal supraoccipital bone morphology|decreased length of long bones|ectopic cartilage|fused joints|hyoid bone hypoplasia|neonatal lethality complete penetrance|small basioccipital bone","extracellular region|multicellular organism development|signaling receptor binding|Wnt signaling pathway|animal organ morphogenesis|receptor ligand activity|negative regulation of cell population proliferation|canonical Wnt signaling pathway|protein binding|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|cartilage development|extracellular space|cytokine activity|negative regulation of cell death|neuron differentiation|chondrocyte differentiation|smoothened signaling pathway|positive regulation of smoothened signaling pathway|epithelial cell differentiation|positive regulation of epithelial cell differentiation|embryonic skeletal system morphogenesis|cell fate commitment|embryonic forelimb morphogenesis|frizzled binding|negative regulation of chondrocyte differentiation|negative regulation of cartilage development|anatomical structure development","extracellular region|anatomical structure development|signaling|molecular function regulator activity|receptor ligand activity|programmed cell death|extracellular space|cell differentiation","|R-MMU-162582|R-MMU-195721|R-MMU-3238698",229787,"ENSMUST00000000128|ENSMUST00000108783","",regulatory_region_variant,"","tsl5 (assigned to previous version 9)|tsl1 (assigned to previous version 3)",1,"alternative1|principal4",1,"","","",ENSMUSR00000517535,"",intron_variant,11,59220041,MGI:2446084,Wnt9a,within coordinates of,SNP,C/T,T,C,C,,"","","","","",""
11,74565697,74565697,1,+,-5.25,rs8254328,ENSMUSG00000020741|ENSMUSG00000020745,Cluh|Pafah1b1,"abnormal coat appearance|abnormal seminal vesicle morphology|abnormal skin morphology|abnormal vertebral arch morphology|enlarged seminal vesicle|increased Ly6C-positive mature NK cell number|no spontaneous movement|preweaning lethality complete penetrance|abnormal homeostasis|abnormal liver physiology|abnormal mitochondrial matrix morphology|abnormal mitochondrial morphology|abnormal tricarboxylic acid cycle|decreased body weight|decreased embryo weight|decreased fasting circulating glucose level|neonatal lethality complete penetrance"|"abnormal acrosome morphology|abnormal dentate gyrus morphology|abnormal germ cell morphology|abnormal hippocampus morphology|abnormal hippocampus pyramidal cell layer|abnormal neocortex morphology|abnormal neuronal migration|abnormal olfactory bulb morphology|abnormal radial glial cell morphology|abnormal seminiferous tubule morphology|abnormal spatial learning|abnormal spermatid morphology|abnormal spermatogonia morphology|abnormal spermiation|abnormal spermiogenesis|abnormal stratification in cerebral cortex|abnormal telencephalon development|abnormal testis morphology|absent hippocampus stratum oriens|arrest of spermiogenesis|azoospermia|decreased body size|delayed brain development|ectopic Purkinje cell|embryonic lethality at implantation complete penetrance|embryonic lethality between implantation and somite formation complete penetrance|embryonic lethality complete penetrance|enlarged brain ventricles|impaired coordination|increased neuron apoptosis|limb grasping|male infertility|postnatal lethality complete penetrance|small testis","protein binding|organelle organization|cytoplasm|RNA binding|mitochondrion organization"|"protein binding|protein-containing complex binding|adult locomotory behavior|brain morphogenesis|cell migration|cytosol|cytoplasm|axon|negative regulation of neuron projection development|nucleus|lipid metabolic process|membrane|neuronal cell body|perinuclear region of cytoplasm|nervous system development|microtubule cytoskeleton|microtubule organizing center|cytoskeleton|glutamatergic synapse|neuron projection|microtubule|cell differentiation|cell cycle|lipid catabolic process|growth cone|cell division|establishment of localization in cell|identical protein binding|motile cilium|spindle|nuclear membrane|nuclear envelope|protein heterodimerization activity|establishment of mitotic spindle orientation|Schaffer collateral - CA1 synapse|centrosome|neuron migration|regulation of GTPase activity|vesicle|cell leading edge|dynein intermediate chain binding|microtubule associated complex|vesicle transport along microtubule|cerebral cortex neuron differentiation|cell cortex|neuromuscular process controlling balance|nuclear migration|neuroblast proliferation|corpus callosum morphogenesis|germ cell development|microtubule binding|microtubule cytoskeleton organization|JNK cascade|microtubule-based process|chemical synaptic transmission|modulation of chemical synaptic transmission|hippocampus development|cerebral cortex development|stem cell division|positive regulation of axon extension|microtubule plus-end binding|acrosome assembly|transmission of nerve impulse|axon cytoplasm|dynein complex binding|actin cytoskeleton organization|learning or memory|stereocilium|kinetochore|protein secretion|nuclear membrane disassembly|phosphoprotein binding|interneuron migration|kinesin complex|osteoclast development|regulation of postsynapse organization|positive regulation of mitotic cell cycle|retrograde axonal transport|layer formation in cerebral cortex|negative regulation of JNK cascade|positive regulation of cytokine-mediated signaling pathway|myeloid leukocyte migration|establishment of centrosome localization|central region of growth cone|ameboidal-type cell migration|brain development|microtubule organizing center organization|reelin-mediated signaling pathway|positive regulation of embryonic development|establishment of planar polarity of embryonic epithelium|cortical microtubule organization|microtubule sliding|positive regulation of cellular component organization|maintenance of centrosome location|auditory receptor cell development|positive regulation of dendritic spine morphogenesis|regulation of microtubule cytoskeleton organization|cochlea development|microtubule cytoskeleton organization involved in establishment of planar polarity|radial glia-guided pyramidal neuron migration|cytoplasmic microtubule|astral microtubule|1-alkyl-2-acetylglycerophosphocholine esterase complex","RNA binding|mitochondrion organization"|"anatomical structure development|cell motility|cytosol|cell differentiation|organelle|nucleus|lipid metabolic process|cytoskeleton|microtubule organizing center|cilium|nuclear envelope|cytoskeleton organization|mitotic cell cycle|establishment or maintenance of cell polarity|microtubule-based movement|nervous system process|reproductive process|cytoskeletal protein binding|signaling|chromosome|membrane organization|immune system process|cell junction organization",""|"R-MMU-5653656|R-MMU-1640170|R-MMU-2555396|R-MMU-68882|R-MMU-68886|R-MMU-69278|R-MMU-162582|R-MMU-453274|R-MMU-69275|R-MMU-199991|R-MMU-6811442|R-MMU-8856688|R-MMU-194315|R-MMU-9716542|R-MMU-1852241|R-MMU-5617833|R-MMU-195258|R-MMU-2565942|R-MMU-380259|R-MMU-380270|R-MMU-380284|R-MMU-380287|R-MMU-380320|R-MMU-5620912|R-MMU-68877|R-MMU-8854518|R-MMU-141424|R-MMU-141444|R-MMU-2467813|R-MMU-2500257|R-MMU-5663220|R-MMU-69618|R-MMU-69620|R-MMU-9648025|R-MMU-6811436|",""|202013,""|"ENSMUST00000021091|ENSMUST00000102520","",""|regulatory_region_variant,"",""|"tsl1 (assigned to previous version 14)|tsl1 (assigned to previous version 8)",""|1,""|principal1,1|-1,"","","",ENSMUSR00000782945,"",downstream_gene_variant|"non_coding_transcript_exon_variant|3_prime_UTR_variant",11,74565697,MGI:109520,Pafah1b1,within coordinates of,SNP,A/T,A,T,T,,"",A,"","","",""
12,57589053,57589053,1,+,-6.36999988555908,rs13481474,ENSMUSG00000035451,Foxa1,"abnormal adrenal gland secretion|abnormal branching of the mammary ductal tree|abnormal circulating insulin level|abnormal glucose homeostasis|decreased body weight|decreased circulating HDL cholesterol level|decreased circulating glucagon level|decreased circulating insulin level|decreased circulating triglyceride level|decreased insulin secretion|hypoglycemia|impaired glucose tolerance|increased circulating cortisol level|increased circulating growth hormone level|increased mammary gland apoptosis|postnatal growth retardation|postnatal lethality complete penetrance","regulation of DNA-templated transcription|DNA-binding transcription factor activity|sequence-specific DNA binding|protein domain specific binding|transcription factor binding|lung development|nucleus|positive regulation of transcription by RNA polymerase II|regulation of gene expression|negative regulation of transcription by RNA polymerase II|regulation of cell cycle|regulation of transcription by RNA polymerase II|RNA polymerase II cis-regulatory region sequence-specific DNA binding|chromatin binding|transcription cis-regulatory region binding|nucleoplasm|neuron differentiation|DNA binding|DNA-binding transcription factor activity, RNA polymerase II-specific|chromatin organization|DNA-binding transcription activator activity, RNA polymerase II-specific|cell differentiation|glucose homeostasis|chromatin remodeling|sequence-specific double-stranded DNA binding|fibrillar center|double-stranded DNA binding|microvillus|RNA polymerase II-specific DNA-binding transcription factor binding|positive regulation of apoptotic process|positive regulation of DNA-binding transcription factor activity|hormone metabolic process|response to estradiol|smoothened signaling pathway|neuron fate specification|dopaminergic neuron differentiation|tube morphogenesis|positive regulation of smoothened signaling pathway|negative regulation of epithelial to mesenchymal transition|anatomical structure morphogenesis|Notch signaling pathway|epithelial tube branching involved in lung morphogenesis|lung morphogenesis|prostate gland epithelium morphogenesis|epithelial cell maturation involved in prostate gland development|positive regulation of hydrogen peroxide-mediated programmed cell death|dorsal/ventral neural tube patterning|positive regulation of mitotic cell cycle|lung epithelial cell differentiation|anatomical structure formation involved in morphogenesis|connective tissue development|prostate gland stromal morphogenesis|positive regulation of intracellular estrogen receptor signaling pathway|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development|epithelial-mesenchymal signaling involved in prostate gland development|alveolar secondary septum development|respiratory basal cell differentiation|positive regulation of dopaminergic neuron differentiation","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|DNA binding|anatomical structure development|organelle|nucleus|nucleoplasm|cell differentiation|chromatin organization|nucleolus|programmed cell death|signaling|reproductive process|mitotic cell cycle","R-MMU-162582|R-MMU-9006931|R-MMU-8939211|R-MMU-9018519",200351,ENSMUST00000044380,"deleterious|",regulatory_region_variant,TF_binding_site_variant,tsl1 (assigned to previous version 7),1,principal1,-1,Mapping of a chromosome 12 region associated with airway hyperresponsiveness in a recombinant congenic mouse strain and selection of potential candidate genes by expression and sequence variation analyses.,"H/R|","ENSPFM0057|ENSPFM0072|ENSPFM0045","ENSMUSR00000331113|ENSMUSR00000788841",0.02,"missense_variant|downstream_gene_variant",12,57589053,MGI:1347472,Foxa1,within coordinates of,SNP,C/T,C,C,T,,"","","","","",""
15,52946367,52946367,1,+,-6.21000003814697,rs31922649,ENSMUSG00000061731,Ext1,"abnormal developmental patterning|abnormal embryonic tissue morphology|abnormal extraembryonic tissue morphology|abnormal eye morphology|abnormal limb morphology|abnormal long bone epiphyseal plate proliferative zone|abnormal skeleton morphology|absent mesoderm|decreased embryo size|disorganized embryonic tissue|embryonic lethality|embryonic lethality between implantation and somite formation complete penetrance|failure of primitive streak formation|failure to gastrulate|increased osteochondroma incidence|no abnormal phenotype detected|premature death|prenatal lethality complete penetrance","integral component of membrane|glycosyltransferase activity|endoplasmic reticulum|protein glycosylation|glucuronosyltransferase activity|heparan sulfate proteoglycan biosynthetic process|gene expression|canonical Wnt signaling pathway|hematopoietic stem cell differentiation|multicellular organism growth|BMP signaling pathway|cell morphogenesis|regulation of blood pressure|ossification|cell population proliferation|cellular response to virus|response to virus|glandular epithelial cell differentiation|social behavior|synaptic transmission, glutamatergic|synapse|membrane|transferase activity|Golgi membrane|Golgi apparatus|metal ion binding|endoplasmic reticulum membrane|protein homodimerization activity|brain development|endoderm development|sulfation|protein heterodimerization activity|protein catabolic process|protein-containing complex assembly|hematopoietic progenitor cell differentiation|optic nerve development|bone resorption|hematopoietic stem cell homeostasis|collagen fibril organization|chondrocyte differentiation|neuron projection development|smoothened signaling pathway|cranial skeletal system development|cell adhesion|cell adhesion mediated by integrin|blood vessel remodeling|olfactory bulb development|epithelium development|fibroblast growth factor receptor signaling pathway|cellular response to fibroblast growth factor stimulus|tight junction organization|gastrulation|cell surface receptor signaling pathway|acetylglucosaminyltransferase activity|sodium ion homeostasis|stem cell division|vocalization behavior|cell fate commitment|ossification involved in bone maturation|chondrocyte proliferation|antigen processing and presentation|bone morphogenesis|dendritic cell migration|heart contraction|epithelial tube branching involved in lung morphogenesis|cellular response to BMP stimulus|axon guidance|hair cycle process|vasodilation|heparin biosynthetic process|motor behavior|wound healing|TNFSF11-mediated signaling pathway|glycosaminoglycan biosynthetic process|hair follicle morphogenesis|endochondral ossification|basement membrane organization|proteoglycan biosynthetic process|leukocyte tethering or rolling|limb joint morphogenesis|endochondral bone morphogenesis|glomerular basement membrane development|cartilage development involved in endochondral bone morphogenesis|mesoderm development|vacuole organization|response to light intensity|fear response|mesenchyme development|embryonic morphogenesis|neural crest cell differentiation|podocyte differentiation|multicellular organismal water homeostasis|developmental growth involved in morphogenesis|sebaceous gland development|response to growth factor|endochondral bone growth|mesenchymal cell differentiation involved in bone development|heparin metabolic process|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|cellular polysaccharide biosynthetic process|fluid transport|stomach development|hypersensitivity|heart field specification|chondrocyte hypertrophy|cellular component organization|chondroitin sulfate metabolic process|lymphocyte adhesion to endothelial cell of high endothelial venule|smoothened signaling pathway involved in lung development|sweat gland development|perichondral bone morphogenesis|dendrite self-avoidance|response to heparin|embryonic skeletal joint development|lymphocyte migration into lymphoid organs|hematopoietic stem cell migration to bone marrow|bone growth|response to leukemia inhibitory factor","catalytic activity|transferase activity|organelle|endoplasmic reticulum|carbohydrate derivative metabolic process|protein modification process|protein glycosylation|signaling|immune system process|anatomical structure development|cell differentiation|circulatory system process|Golgi apparatus|sulfur compound metabolic process|protein catabolic process|protein-containing complex assembly|extracellular matrix organization|cell adhesion|cell junction organization|metal ion homeostasis|cell motility|wound healing|carbohydrate metabolic process|inflammatory response","R-MMU-1430728|R-MMU-71387|R-MMU-1630316|R-MMU-1638091|R-MMU-2022928|",199556,ENSMUST00000077273,"",regulatory_region_variant,TF_binding_site_variant,tsl1 (assigned to previous version 8),1,principal1,-1,"","",ENSPFM0011,ENSMUSR00000803833,"","intron_variant|NMD_transcript_variant|downstream_gene_variant",15,52946367,MGI:894663,Ext1,within coordinates of,SNP,C/T,C,C,T,,"","","","","",""
15,52999187,52999187,1,+,-5.84000015258789,rs32415682,ENSMUSG00000061731,Ext1,"abnormal developmental patterning|abnormal embryonic tissue morphology|abnormal extraembryonic tissue morphology|abnormal eye morphology|abnormal limb morphology|abnormal long bone epiphyseal plate proliferative zone|abnormal skeleton morphology|absent mesoderm|decreased embryo size|disorganized embryonic tissue|embryonic lethality|embryonic lethality between implantation and somite formation complete penetrance|failure of primitive streak formation|failure to gastrulate|increased osteochondroma incidence|no abnormal phenotype detected|premature death|prenatal lethality complete penetrance","integral component of membrane|glycosyltransferase activity|endoplasmic reticulum|protein glycosylation|glucuronosyltransferase activity|heparan sulfate proteoglycan biosynthetic process|gene expression|canonical Wnt signaling pathway|hematopoietic stem cell differentiation|multicellular organism growth|BMP signaling pathway|cell morphogenesis|regulation of blood pressure|ossification|cell population proliferation|cellular response to virus|response to virus|glandular epithelial cell differentiation|social behavior|synaptic transmission, glutamatergic|synapse|membrane|transferase activity|Golgi membrane|Golgi apparatus|metal ion binding|endoplasmic reticulum membrane|protein homodimerization activity|brain development|endoderm development|sulfation|protein heterodimerization activity|protein catabolic process|protein-containing complex assembly|hematopoietic progenitor cell differentiation|optic nerve development|bone resorption|hematopoietic stem cell homeostasis|collagen fibril organization|chondrocyte differentiation|neuron projection development|smoothened signaling pathway|cranial skeletal system development|cell adhesion|cell adhesion mediated by integrin|blood vessel remodeling|olfactory bulb development|epithelium development|fibroblast growth factor receptor signaling pathway|cellular response to fibroblast growth factor stimulus|tight junction organization|gastrulation|cell surface receptor signaling pathway|acetylglucosaminyltransferase activity|sodium ion homeostasis|stem cell division|vocalization behavior|cell fate commitment|ossification involved in bone maturation|chondrocyte proliferation|antigen processing and presentation|bone morphogenesis|dendritic cell migration|heart contraction|epithelial tube branching involved in lung morphogenesis|cellular response to BMP stimulus|axon guidance|hair cycle process|vasodilation|heparin biosynthetic process|motor behavior|wound healing|TNFSF11-mediated signaling pathway|glycosaminoglycan biosynthetic process|hair follicle morphogenesis|endochondral ossification|basement membrane organization|proteoglycan biosynthetic process|leukocyte tethering or rolling|limb joint morphogenesis|endochondral bone morphogenesis|glomerular basement membrane development|cartilage development involved in endochondral bone morphogenesis|mesoderm development|vacuole organization|response to light intensity|fear response|mesenchyme development|embryonic morphogenesis|neural crest cell differentiation|podocyte differentiation|multicellular organismal water homeostasis|developmental growth involved in morphogenesis|sebaceous gland development|response to growth factor|endochondral bone growth|mesenchymal cell differentiation involved in bone development|heparin metabolic process|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|cellular polysaccharide biosynthetic process|fluid transport|stomach development|hypersensitivity|heart field specification|chondrocyte hypertrophy|cellular component organization|chondroitin sulfate metabolic process|lymphocyte adhesion to endothelial cell of high endothelial venule|smoothened signaling pathway involved in lung development|sweat gland development|perichondral bone morphogenesis|dendrite self-avoidance|response to heparin|embryonic skeletal joint development|lymphocyte migration into lymphoid organs|hematopoietic stem cell migration to bone marrow|bone growth|response to leukemia inhibitory factor","catalytic activity|transferase activity|organelle|endoplasmic reticulum|carbohydrate derivative metabolic process|protein modification process|protein glycosylation|signaling|immune system process|anatomical structure development|cell differentiation|circulatory system process|Golgi apparatus|sulfur compound metabolic process|protein catabolic process|protein-containing complex assembly|extracellular matrix organization|cell adhesion|cell junction organization|metal ion homeostasis|cell motility|wound healing|carbohydrate metabolic process|inflammatory response","R-MMU-1430728|R-MMU-71387|R-MMU-1630316|R-MMU-1638091|R-MMU-2022928|",199556,ENSMUST00000077273,"",regulatory_region_variant,TF_binding_site_variant,tsl1 (assigned to previous version 8),1,principal1,-1,"","","ENSPFM0036|ENSPFM0037|ENSPFM0064|ENSPFM0063",ENSMUSR00000571871,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant",15,52999187,MGI:894663,Ext1,within coordinates of,SNP,C/T,C,C,T,,"","","","","",""
17,25296864,25296864,1,+,-8.1899995803833,rs33403687,ENSMUSG00000024168|ENSMUSG00000024169,Tmem204|Ift140,"abnormal lymphatic vessel smooth muscle morphology|enlarged lymphatic vessel"|"abnormal aortic arch morphology|abnormal atrioventricular valve morphology|abnormal costovertebral joint morphology|abnormal craniofacial morphology|abnormal digit morphology|abnormal exoccipital bone morphology|abnormal heart looping|abnormal heart ventricle morphology|abnormal hindlimb bud morphology|abnormal interventricular septum morphology|abnormal limb bud morphology|abnormal lung morphology|abnormal maxilla morphology|abnormal mouth morphology|abnormal neural tube closure|abnormal neural tube morphology|abnormal primary cilium morphology|abnormal rib morphology|abnormal somite development|abnormal tricuspid valve morphology|absent alisphenoid bone|absent facial bone|absent neurocranium|absent palatine bone|absent spleen|absent tympanic ring|anophthalmia|atrioventricular septal defect|cervical vertebral fusion|cleft palate|curly tail|embryonic lethality during organogenesis complete penetrance|embryonic lethality complete penetrance|exencephaly|exostosis|facial bone hypoplasia|fusion of atlas and occipital bones|heart hemorrhage|hydrops fetalis|kidney cyst|left pulmonary isomerism|lethality throughout fetal growth and development complete penetrance|lethality throughout fetal growth and development incomplete penetrance|maxilla hypoplasia|oligodactyly|omphalocele|palatal shelf hypoplasia|persistent truncus arteriosis|polydactyly|premaxilla hypoplasia|prenatal growth retardation|rib bifurcation|right aortic arch|spina bifida","protein binding|membrane|plasma membrane|anchoring junction|adherens junction|lymph vessel development|smooth muscle cell differentiation|regulation of vascular endothelial growth factor receptor signaling pathway"|"protein binding|molecular_function|embryonic brain development|heart development|embryonic cranial skeleton morphogenesis|cytoplasm|microtubule organizing center|cell projection organization|cytoskeleton|cell projection|cilium|axoneme|non-motile cilium|photoreceptor cell outer segment organization|centrosome|centriole|cilium assembly|ciliary basal body|photoreceptor connecting cilium|determination of left/right symmetry|intraciliary transport|protein localization to cilium|regulation of cilium assembly|limb morphogenesis|embryonic digit morphogenesis|non-motile cilium assembly|regulation of smoothened signaling pathway|neural tube patterning|embryonic camera-type eye development|intraciliary retrograde transport|intraciliary transport particle A|cone photoreceptor outer segment","plasma membrane|anatomical structure development|cell differentiation|signaling"|"anatomical structure development|organelle|cytoskeleton|microtubule organizing center|cilium|cell differentiation|cilium organization|microtubule-based movement|signaling",""|"|R-MMU-162582|R-MMU-1852241|R-MMU-5617833|R-MMU-5358351|R-MMU-5610787|R-MMU-5620924",240475|"",""|"ENSMUST00000024983|ENSMUST00000142000|ENSMUST00000153895","",""|regulatory_region_variant,""|TF_binding_site_variant,""|"tsl1 (assigned to previous version 11)|tsl1 (assigned to previous version 7)",""|1,""|"principal2|alternative2|",-1|1,"","",ENSPFM0012,ENSMUSR00000120324,"","intron_variant|non_coding_transcript_variant",17,25296864,MGI:2146906,Ift140,within coordinates of,SNP,A/T,T,T,A,,"","","","","",""
3,51717341,51717341,1,+,-5.01999998092651,rs30797645,ENSMUSG00000061143,Maml3,no abnormal phenotype detected,"transcription coactivator activity|positive regulation of transcription of Notch receptor target|nucleus|nuclear speck|positive regulation of transcription by RNA polymerase II|nucleoplasm|Notch signaling pathway","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|signaling|organelle|nucleus|nucleoplasm","|R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-162582|R-MMU-157118|R-MMU-1980143|R-MMU-2122947|R-MMU-350054|R-MMU-8878159|R-MMU-8941856","",ENSMUST00000121440,"",regulatory_region_variant,"",tsl1 (assigned to previous version 3),1,principal1,-1,"","","",ENSMUSR00000400905,"",intron_variant,3,51717341,MGI:2389461,Maml3,within coordinates of,SNP,A/G,A,A,G,,"","","","","",
4,136233431,136233431,1,+,-6,rs27582092,ENSMUSG00000001089,Luzp1,"abnormal hindbrain morphology|abnormal neural fold morphology|abnormal pons morphology|abnormal rhombic lip morphology|abnormal roof plate morphology|anencephaly|cleft secondary palate|cyanosis|double outlet right ventricle|enlarged brain ventricles|exencephaly|failure of eyelid fusion|incomplete rostral neuropore closure|increased hindbrain apoptosis|omphalocele|palatal shelves fail to meet at midline|perinatal lethality complete penetrance|prenatal lethality incomplete penetrance|transposition of great arteries|ventricular septal defect","molecular_function|nucleus|cytoplasm|microtubule organizing center|cytoskeleton|centrosome|artery development|ventricular septum development|neural fold bending","organelle|nucleus|cytoskeleton|microtubule organizing center|anatomical structure development","",234675,ENSMUST00000170102,"",regulatory_region_variant,"",tsl5 (assigned to previous version 7),1,principal1,1,"","","",ENSMUSR00000417730,"","intron_variant|non_coding_transcript_variant",4,136233431,MGI:107629,Luzp1,within coordinates of,SNP,A/T,T,T,A,,"","","","","",""
4,136233483,136233483,1,+,-6.6399998664856,rs27582091,ENSMUSG00000001089,Luzp1,"abnormal hindbrain morphology|abnormal neural fold morphology|abnormal pons morphology|abnormal rhombic lip morphology|abnormal roof plate morphology|anencephaly|cleft secondary palate|cyanosis|double outlet right ventricle|enlarged brain ventricles|exencephaly|failure of eyelid fusion|incomplete rostral neuropore closure|increased hindbrain apoptosis|omphalocele|palatal shelves fail to meet at midline|perinatal lethality complete penetrance|prenatal lethality incomplete penetrance|transposition of great arteries|ventricular septal defect","molecular_function|nucleus|cytoplasm|microtubule organizing center|cytoskeleton|centrosome|artery development|ventricular septum development|neural fold bending","organelle|nucleus|cytoskeleton|microtubule organizing center|anatomical structure development","",234675,ENSMUST00000170102,"",regulatory_region_variant,"",tsl5 (assigned to previous version 7),1,principal1,1,"","","",ENSMUSR00000417730,"","intron_variant|non_coding_transcript_variant",4,136233483,MGI:107629,Luzp1,within coordinates of,SNP,A/C,C,C,A,,"","","","","",""
4,32404230,32404230,1,+,-5.59000015258789,rs27804891,ENSMUSG00000040270,Bach2,"abnormal bone structure|abnormal optic disk morphology|decreased B cell number|decreased B-1a cell number|decreased B-2 B cell number|decreased CD11b-high dendritic cell number|decreased CD4-negative NK T cell number|decreased CD8-positive naive alpha-beta T cell number|decreased Ly6C-positive immature NK cell number|decreased Ly6C-positive mature NK cell number|decreased NK T cell number|decreased NK cell number|decreased bone mineral content|decreased bone mineral density|decreased circulating creatinine level|decreased circulating glucose level|decreased effector memory CD8-positive alpha-beta T cell number|decreased exploration in new environment|decreased follicular B cell number|decreased food intake|decreased marginal zone B cell number|decreased mature B cell number|decreased memory-marker CD4-negative NK T cell number|decreased memory-marker NK cell number|decreased prepulse inhibition|decreased regulatory T cell number|decreased respiratory quotient|decreased transitional stage B cell number|decreased vertical activity|hyperactivity|immune system phenotype|increased CD103-positive CD11b-low dendritic cell number|increased CD11b-low dendritic cell number|increased CD4-positive alpha-beta memory T cell number|increased CD8-positive alpha-beta memory T cell number|increased KLRG1+ CD4 alpha beta T cell number|increased KLRG1+ CD8 alpha beta T cell number|increased KLRG1-positive CD4-negative NK T cell number|increased KLRG1-positive CD4-positive CD25-positive alpha-beta regulatory T cell number|increased KLRG1-positive NK cell number|increased KLRG1-positive gamma-delta T cell number|increased Ly6C high monocyte number|increased Ly6C low monocyte number|increased NK T cell number|increased NK cell number|increased circulating alkaline phosphatase level|increased circulating amylase level|increased circulating aspartate transaminase level|increased circulating iron level|increased circulating unsaturated transferrin level|increased effector memory CD8-positive alpha-beta T cell number|increased effector memory T-helper cell number|increased eosinophil cell number|increased granulocyte number|increased grip strength|increased immature B cell number|increased macrophage cell number|increased memory CD4-positive CD25-positive alpha-beta regulatory T cell number|increased memory-marker CD4-negative NK T cell number|increased memory-marker NK cell number|increased monocyte cell number|increased neutrophil cell number|increased pulmonary respiratory rate|limb grasping|short tibia|thrombocytosis|abnormal B cell differentiation|abnormal B cell physiology|abnormal class switch recombination|abnormal somatic hypermutation frequency|absent germinal center B cells|decreased CD4-positive alpha beta T cell number|decreased IgA level|decreased IgG level|decreased IgG1 level|decreased IgG2a level|decreased IgG2b level|decreased IgG3 level|increased B-1 B cell number|increased IgM level|myeloid hyperplasia|spleen hypoplasia","DNA binding|regulation of DNA-templated transcription|protein binding|DNA-binding transcription factor activity|nucleus|cytosol|nucleoplasm|cytoplasm|RNA polymerase II cis-regulatory region sequence-specific DNA binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|sequence-specific double-stranded DNA binding|RNA polymerase II transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|negative regulation of transcription by RNA polymerase II|import into nucleus|ion binding|primary adaptive immune response involving T cells and B cells","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus|cytosol|nucleoplasm|nucleocytoplasmic transport|immune system process","",198295,ENSMUST00000108180,"",regulatory_region_variant,"",tsl5 (assigned to previous version 8),1,principal1,1,"","","",ENSMUSR00000410065,"","intron_variant|non_coding_transcript_variant",4,32404230,MGI:894679,Bach2,within coordinates of,SNP,C/T,C,C,T,,"","","","","",
4,32425302,32425302,1,+,-7.92000007629395,rs27804816,ENSMUSG00000040270,Bach2,"abnormal bone structure|abnormal optic disk morphology|decreased B cell number|decreased B-1a cell number|decreased B-2 B cell number|decreased CD11b-high dendritic cell number|decreased CD4-negative NK T cell number|decreased CD8-positive naive alpha-beta T cell number|decreased Ly6C-positive immature NK cell number|decreased Ly6C-positive mature NK cell number|decreased NK T cell number|decreased NK cell number|decreased bone mineral content|decreased bone mineral density|decreased circulating creatinine level|decreased circulating glucose level|decreased effector memory CD8-positive alpha-beta T cell number|decreased exploration in new environment|decreased follicular B cell number|decreased food intake|decreased marginal zone B cell number|decreased mature B cell number|decreased memory-marker CD4-negative NK T cell number|decreased memory-marker NK cell number|decreased prepulse inhibition|decreased regulatory T cell number|decreased respiratory quotient|decreased transitional stage B cell number|decreased vertical activity|hyperactivity|immune system phenotype|increased CD103-positive CD11b-low dendritic cell number|increased CD11b-low dendritic cell number|increased CD4-positive alpha-beta memory T cell number|increased CD8-positive alpha-beta memory T cell number|increased KLRG1+ CD4 alpha beta T cell number|increased KLRG1+ CD8 alpha beta T cell number|increased KLRG1-positive CD4-negative NK T cell number|increased KLRG1-positive CD4-positive CD25-positive alpha-beta regulatory T cell number|increased KLRG1-positive NK cell number|increased KLRG1-positive gamma-delta T cell number|increased Ly6C high monocyte number|increased Ly6C low monocyte number|increased NK T cell number|increased NK cell number|increased circulating alkaline phosphatase level|increased circulating amylase level|increased circulating aspartate transaminase level|increased circulating iron level|increased circulating unsaturated transferrin level|increased effector memory CD8-positive alpha-beta T cell number|increased effector memory T-helper cell number|increased eosinophil cell number|increased granulocyte number|increased grip strength|increased immature B cell number|increased macrophage cell number|increased memory CD4-positive CD25-positive alpha-beta regulatory T cell number|increased memory-marker CD4-negative NK T cell number|increased memory-marker NK cell number|increased monocyte cell number|increased neutrophil cell number|increased pulmonary respiratory rate|limb grasping|short tibia|thrombocytosis|abnormal B cell differentiation|abnormal B cell physiology|abnormal class switch recombination|abnormal somatic hypermutation frequency|absent germinal center B cells|decreased CD4-positive alpha beta T cell number|decreased IgA level|decreased IgG level|decreased IgG1 level|decreased IgG2a level|decreased IgG2b level|decreased IgG3 level|increased B-1 B cell number|increased IgM level|myeloid hyperplasia|spleen hypoplasia","DNA binding|regulation of DNA-templated transcription|protein binding|DNA-binding transcription factor activity|nucleus|cytosol|nucleoplasm|cytoplasm|RNA polymerase II cis-regulatory region sequence-specific DNA binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|sequence-specific double-stranded DNA binding|RNA polymerase II transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|negative regulation of transcription by RNA polymerase II|import into nucleus|ion binding|primary adaptive immune response involving T cells and B cells","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus|cytosol|nucleoplasm|nucleocytoplasmic transport|immune system process","",198295,"ENSMUST00000108180|ENSMUST00000171600","",regulatory_region_variant,TF_binding_site_variant,"tsl5 (assigned to previous version 8)|tsl1 (assigned to previous version 1)",1,principal1,1,"","",ENSPFM0085,ENSMUSR00000838754,"","intron_variant|non_coding_transcript_variant",4,32425302,MGI:894679,Bach2,within coordinates of,SNP,C/T,T,T,C,,"","","","","",
5,103880236,103880236,1,+,-5.09999990463257,rs32020278,ENSMUSG00000029313,Aff1,"Purkinje cell degeneration|abnormal T cell differentiation|abnormal cerebellum morphology|abnormal double-negative T cell morphology|abnormal immune system cell morphology|abnormal immune system organ morphology|abnormal stationary movement|ataxia|cataract|decreased B cell number|decreased body size|decreased double-positive T cell number|decreased mature B cell number|decreased pre-B cell number|decreased single-positive T cell number|decreased thymus weight|female infertility|gliosis|impaired balance|jerky movement|postnatal lethality incomplete penetrance|preweaning lethality incomplete penetrance|reduced male fertility|thin cerebellar molecular layer|thymus hypoplasia","nucleus|regulation of gene expression|transcription elongation factor complex","organelle|nucleus|nucleoplasm","","",ENSMUST00000126335,"",regulatory_region_variant,"",tsl1 (assigned to previous version 1),"","",1,"","","",ENSMUSR00000849469,"","non_coding_transcript_variant|intron_variant",5,103880236,MGI:1100819,Aff1,within coordinates of,SNP,C/T,T,T,C,,"","","","","",
5,118734838,118734838,1,+,-5.82000017166138,rs33583463,ENSMUSG00000018076,Med13l,"abnormal craniofacial morphology|abnormal facial morphology|embryonic growth retardation|microphthalmia","regulation of transcription by RNA polymerase II|transcription coregulator activity|mediator complex|nucleus|DNA-templated transcription","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus","","",ENSMUST00000201010,"",regulatory_region_variant,TF_binding_site_variant,tsl5 (assigned to previous version 1),1,principal4,1,"","",ENSPFM0068,ENSMUSR00000850613,"","non_coding_transcript_variant|intron_variant|downstream_gene_variant",5,118734838,MGI:2670178,Med13l,within coordinates of,SNP,A/G,A,G,G,,"","","","","",
5,118737202,118737202,1,+,-6.94999980926514,rs33139990,ENSMUSG00000018076|ENSMUSG00000107286,Med13l|Gm43788,"abnormal craniofacial morphology|abnormal facial morphology|embryonic growth retardation|microphthalmia"|"","regulation of transcription by RNA polymerase II|transcription coregulator activity|mediator complex|nucleus|DNA-templated transcription"|"","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus"|"","","",ENSMUST00000201010|"","",regulatory_region_variant|"","",tsl5 (assigned to previous version 1)|"",1|"",principal4|"",1,"","","",ENSMUSR00000427597,"","non_coding_transcript_variant|intron_variant"|upstream_gene_variant,5,118737202,MGI:2670178,Med13l,within coordinates of,SNP,C/G,C,G,G,,"","","","","",
5,118756066,118756066,1,+,-6.69999980926514,rs29506614,ENSMUSG00000018076|ENSMUSG00000106798,Med13l|Gm43275,"abnormal craniofacial morphology|abnormal facial morphology|embryonic growth retardation|microphthalmia"|"","regulation of transcription by RNA polymerase II|transcription coregulator activity|mediator complex|nucleus|DNA-templated transcription"|"","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus"|"","","",ENSMUST00000201010|"","",regulatory_region_variant|"","",tsl5 (assigned to previous version 1)|"",1|"",principal4|"",1,"","","",ENSMUSR00000850618,"","non_coding_transcript_variant|intron_variant"|upstream_gene_variant,5,118756066,MGI:2670178,Med13l,within coordinates of,SNP,C/T,C,T,T,,"","","","","",
5,118756089,118756089,1,+,-7.75,rs33102980,ENSMUSG00000018076|ENSMUSG00000106798,Med13l|Gm43275,"abnormal craniofacial morphology|abnormal facial morphology|embryonic growth retardation|microphthalmia"|"","regulation of transcription by RNA polymerase II|transcription coregulator activity|mediator complex|nucleus|DNA-templated transcription"|"","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus"|"","","",ENSMUST00000201010|"","",regulatory_region_variant|"","",tsl5 (assigned to previous version 1)|"",1|"",principal4|"",1,"","","",ENSMUSR00000850618,"","non_coding_transcript_variant|intron_variant"|upstream_gene_variant,5,118756089,MGI:2670178,Med13l,within coordinates of,SNP,A/G,G,A,A,,"","","","","",
5,118838331,118838331,1,+,-5.05999994277954,rs33503624,ENSMUSG00000018076,Med13l,"abnormal craniofacial morphology|abnormal facial morphology|embryonic growth retardation|microphthalmia","regulation of transcription by RNA polymerase II|transcription coregulator activity|mediator complex|nucleus|DNA-templated transcription","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus","","",ENSMUST00000201010,"",regulatory_region_variant,"",tsl5 (assigned to previous version 1),1,principal4,1,"","","",ENSMUSR00000850627,"","non_coding_transcript_variant|intron_variant",5,118838331,MGI:2670178,Med13l,within coordinates of,SNP,C/T,T,C,C,,"","","","","",
5,118840244,118840244,1,+,-5.03999996185303,rs29634689,ENSMUSG00000018076,Med13l,"abnormal craniofacial morphology|abnormal facial morphology|embryonic growth retardation|microphthalmia","regulation of transcription by RNA polymerase II|transcription coregulator activity|mediator complex|nucleus|DNA-templated transcription","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus","","",ENSMUST00000201010,"",regulatory_region_variant,"",tsl5 (assigned to previous version 1),1,principal4,1,"","","",ENSMUSR00000850627,"","non_coding_transcript_variant|intron_variant",5,118840244,MGI:2670178,Med13l,within coordinates of,SNP,C/T,C,T,T,,"","","","","",
5,123554627,123554627,1,+,-6.82999992370606,rs33069605,ENSMUSG00000038342|ENSMUSG00000106636,Mlxip|Gm43813,"abnormal muscle physiology|decreased respiratory quotient|enhanced exercise endurance|increased circulating alanine level|increased circulating lactate level|increased fatty acid oxidation"|"","regulation of DNA-templated transcription|DNA-binding transcription factor activity, RNA polymerase II-specific|protein dimerization activity|RNA polymerase II transcription regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity, RNA polymerase II-specific|positive regulation of transcription by RNA polymerase II"|"","DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|DNA binding"|"","","","ENSMUST00000068237|ENSMUST00000111596"|"","",regulatory_region_variant|"","","tsl1 (assigned to previous version 11)|tsl1 (assigned to previous version 7)"|"",1|"","principal1|"|"",1,"","","",ENSMUSR00000428243,"",intron_variant|downstream_gene_variant,5,123554627,MGI:2141183,Mlxip,within coordinates of,SNP,C/G,C,G,G,,"","","","","",
5,125094224,125094224,1,+,-5.84000015258789,rs33230073,ENSMUSG00000029478|ENSMUSG00000037962,Ncor2|Rflna,"abnormal blood vessel morphology|abnormal craniofacial morphology|abnormal placenta morphology|abnormal placenta vasculature|abnormal tail movements|edema|embryonic growth retardation|increased lean body mass|increased prepulse inhibition|increased startle reflex|long tibia|persistence of hyaloid vascular system|preweaning lethality complete penetrance|abnormal bone marrow cavity morphology|abnormal bone marrow cell number|abnormal bone marrow morphology|abnormal bone structure|abnormal cell differentiation|abnormal circulating enzyme level|abnormal circulating hormone level|abnormal eating behavior|abnormal gas homeostasis|abnormal gluconeogenesis|abnormal heart development|abnormal hematopoietic stem cell morphology|abnormal hormone level|abnormal metabolism|abnormal neuronal precursor proliferation|abnormal physiological response to xenobiotic|abnormal skeleton physiology|abnormal spleen morphology|abnormal telencephalon morphology|abnormal trabecular bone morphology|abnormal white adipose tissue physiology|decreased body temperature|decreased body weight|decreased bone strength|decreased carbon dioxide production|decreased circulating insulin level|decreased circulating leptin level|decreased compact bone thickness|decreased energy expenditure|decreased oxygen consumption|decreased susceptibility to diet-induced hepatic steatosis|decreased white fat cell size|enlarged spleen|extramedullary hematopoiesis|hindlimb paresis|increased adiponectin level|increased bone trabecula number|increased circulating glucose level|increased epididymal fat pad weight|increased erythroid progenitor cell number|increased insulin sensitivity|increased megakaryocyte cell number|increased osteoclast cell number|increased percent body fat/body weight|increased susceptibility to diet-induced obesity|increased trabecular bone volume|increased white adipose tissue amount|increased white fat cell number|insulin resistance|lethality throughout fetal growth and development complete penetrance|myelofibrosis|osteosclerosis|prenatal lethality complete penetrance|thin ventricular wall|ventricular septal defect"|"","in utero embryonic development|nucleus|sequence-specific DNA binding|protein binding|gene expression|negative regulation of fat cell differentiation|protein-containing complex binding|negative regulation of transcription by RNA polymerase II|chromatin binding|heart morphogenesis|nuclear body|chromatin|nucleoplasm|DNA binding|regulation of transcription by RNA polymerase II|nuclear matrix|glucose homeostasis|negative regulation of DNA-templated transcription|protein stabilization|transcription corepressor activity|histone deacetylase binding|epidermis development|protein N-terminus binding|nuclear receptor binding|forebrain development|nuclear retinoic acid receptor binding|transcription repressor complex|nuclear glucocorticoid receptor binding|negative regulation of miRNA transcription|establishment of skin barrier|nuclear retinoid X receptor binding|negative regulation of androgen receptor signaling pathway|protein deacetylation|histone deacetylase complex|cell proliferation in forebrain|white fat cell differentiation|Notch binding|positive regulation of protein deacetylation|type I pneumocyte differentiation|telencephalon development|regulation of cellular ketone metabolic process|regulation of histone deacetylase activity|lactation|response to organonitrogen compound|cerebellum development|response to estradiol|estrous cycle"|"filamin binding|regulation of chondrocyte development|actin filament bundle organization|cytoplasm|cytoskeleton|skeletal system morphogenesis|negative regulation of bone mineralization involved in bone maturation|actin filament bundle|negative regulation of chondrocyte development","anatomical structure development|organelle|nucleus|DNA binding|cell differentiation|DNA-templated transcription|regulation of DNA-templated transcription|nucleoplasm|chromosome|transcription regulator activity|signaling|protein modification process|reproductive process"|"cytoskeletal protein binding|anatomical structure development|cell differentiation|cytoskeleton organization|organelle|cytoskeleton","|R-MMU-1266738|R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-1430728|R-MMU-2262752|R-MMU-8953897|R-MMU-162582|R-MMU-556833|R-MMU-170834|R-MMU-9006936|R-MMU-9707564|R-MMU-9711123|R-MMU-9006931|R-MMU-350054|R-MMU-2173793|R-MMU-2173795|R-MMU-9024446|R-MMU-9029569|R-MMU-400206|R-MMU-383280|R-MMU-381340|R-MMU-9623433"|"",203350|215780,"ENSMUST00000111393|ENSMUST00000111394|ENSMUST00000111402|ENSMUST00000125053"|"","",regulatory_region_variant|"","","tsl1 (assigned to previous version 7)|tsl5 (assigned to previous version 8)"|"",1|"","|alternative2"|"",-1|1,"","","",ENSMUSR00000851313,"","3_prime_UTR_variant|downstream_gene_variant"|downstream_gene_variant,5,125094224,MGI:1337080,Ncor2,within coordinates of,SNP,C/T,C,T,T,,"","","","","",
5,125145479,125145479,1,+,-5.51999998092651,rs33424264,ENSMUSG00000029478,Ncor2,"abnormal blood vessel morphology|abnormal craniofacial morphology|abnormal placenta morphology|abnormal placenta vasculature|abnormal tail movements|edema|embryonic growth retardation|increased lean body mass|increased prepulse inhibition|increased startle reflex|long tibia|persistence of hyaloid vascular system|preweaning lethality complete penetrance|abnormal bone marrow cavity morphology|abnormal bone marrow cell number|abnormal bone marrow morphology|abnormal bone structure|abnormal cell differentiation|abnormal circulating enzyme level|abnormal circulating hormone level|abnormal eating behavior|abnormal gas homeostasis|abnormal gluconeogenesis|abnormal heart development|abnormal hematopoietic stem cell morphology|abnormal hormone level|abnormal metabolism|abnormal neuronal precursor proliferation|abnormal physiological response to xenobiotic|abnormal skeleton physiology|abnormal spleen morphology|abnormal telencephalon morphology|abnormal trabecular bone morphology|abnormal white adipose tissue physiology|decreased body temperature|decreased body weight|decreased bone strength|decreased carbon dioxide production|decreased circulating insulin level|decreased circulating leptin level|decreased compact bone thickness|decreased energy expenditure|decreased oxygen consumption|decreased susceptibility to diet-induced hepatic steatosis|decreased white fat cell size|enlarged spleen|extramedullary hematopoiesis|hindlimb paresis|increased adiponectin level|increased bone trabecula number|increased circulating glucose level|increased epididymal fat pad weight|increased erythroid progenitor cell number|increased insulin sensitivity|increased megakaryocyte cell number|increased osteoclast cell number|increased percent body fat/body weight|increased susceptibility to diet-induced obesity|increased trabecular bone volume|increased white adipose tissue amount|increased white fat cell number|insulin resistance|lethality throughout fetal growth and development complete penetrance|myelofibrosis|osteosclerosis|prenatal lethality complete penetrance|thin ventricular wall|ventricular septal defect","in utero embryonic development|nucleus|sequence-specific DNA binding|protein binding|gene expression|negative regulation of fat cell differentiation|protein-containing complex binding|negative regulation of transcription by RNA polymerase II|chromatin binding|heart morphogenesis|nuclear body|chromatin|nucleoplasm|DNA binding|regulation of transcription by RNA polymerase II|nuclear matrix|glucose homeostasis|negative regulation of DNA-templated transcription|protein stabilization|transcription corepressor activity|histone deacetylase binding|epidermis development|protein N-terminus binding|nuclear receptor binding|forebrain development|nuclear retinoic acid receptor binding|transcription repressor complex|nuclear glucocorticoid receptor binding|negative regulation of miRNA transcription|establishment of skin barrier|nuclear retinoid X receptor binding|negative regulation of androgen receptor signaling pathway|protein deacetylation|histone deacetylase complex|cell proliferation in forebrain|white fat cell differentiation|Notch binding|positive regulation of protein deacetylation|type I pneumocyte differentiation|telencephalon development|regulation of cellular ketone metabolic process|regulation of histone deacetylase activity|lactation|response to organonitrogen compound|cerebellum development|response to estradiol|estrous cycle","anatomical structure development|organelle|nucleus|DNA binding|cell differentiation|DNA-templated transcription|regulation of DNA-templated transcription|nucleoplasm|chromosome|transcription regulator activity|signaling|protein modification process|reproductive process","|R-MMU-1266738|R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-1430728|R-MMU-2262752|R-MMU-8953897|R-MMU-162582|R-MMU-556833|R-MMU-170834|R-MMU-9006936|R-MMU-9707564|R-MMU-9711123|R-MMU-9006931|R-MMU-350054|R-MMU-2173793|R-MMU-2173795|R-MMU-9024446|R-MMU-9029569|R-MMU-400206|R-MMU-383280|R-MMU-381340|R-MMU-9623433",203350,"ENSMUST00000111393|ENSMUST00000111394|ENSMUST00000111402","",regulatory_region_variant,"","tsl1 (assigned to previous version 7)|tsl5 (assigned to previous version 8)",1,"|alternative2",-1,"","","",ENSMUSR00000217976,"",intron_variant,5,125145479,MGI:1337080,Ncor2,within coordinates of,SNP,C/T,C,T,T,,"","","","","",
6,136509207,136509207,1,+,-5.15000009536743,rs30862197,ENSMUSG00000030213,Atf7ip,"","nucleus|protein binding|negative regulation of transcription by RNA polymerase II|cytosol|nuclear body|DNA methylation|nucleoplasm|regulation of DNA-templated transcription|DNA-templated transcription|positive regulation of DNA-templated transcription|negative regulation of DNA-templated transcription|transcription coregulator activity|protein stabilization|transcription regulator complex|transcription corepressor activity|ATP hydrolysis activity|regulation of protein stability|positive regulation of DNA methylation-dependent heterochromatin formation|regulation of RNA polymerase II transcription preinitiation complex assembly","organelle|nucleus|DNA-templated transcription|regulation of DNA-templated transcription|cytosol|nucleoplasm|transcription regulator activity|catalytic activity|hydrolase activity|ATP-dependent activity|chromatin organization|protein-containing complex assembly","|R-MMU-3214841|R-MMU-3247509|R-MMU-4839726",207616,ENSMUST00000032335,"",regulatory_region_variant,"",tsl1 (assigned to previous version 12),1,principal1,1,"","","",ENSMUSR00000709194,"","intron_variant|upstream_gene_variant",6,136509207,MGI:1858965,Atf7ip,within coordinates of,SNP,C/G,C,G,G,,"","","","","",
6,32800445,32800445,1,+,-6.65000009536743,rs30516125,ENSMUSG00000053768,Chchd3,embryonic lethality before implantation complete penetrance,"mitochondrion|MICOS complex|membrane|nucleus|cytoplasm|mitochondrial inner membrane|protein binding|phosphatase binding|molecular adaptor activity|mitochondrial fusion|inner mitochondrial membrane organization|cristae formation","organelle|mitochondrion|nucleus|molecular adaptor activity|mitochondrion organization|membrane organization","",211197,ENSMUST00000066379,"",regulatory_region_variant,TF_binding_site_variant,tsl1 (assigned to previous version 10),1,principal1,-1,"","",ENSPFM0021,ENSMUSR00000432804,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant|upstream_gene_variant",6,32800445,MGI:1913325,Chchd3,within coordinates of,SNP,C/T,C,T,T,,"","","","","",
6,32800952,32800952,1,+,-7.71000003814697,rs30123595,ENSMUSG00000053768,Chchd3,embryonic lethality before implantation complete penetrance,"mitochondrion|MICOS complex|membrane|nucleus|cytoplasm|mitochondrial inner membrane|protein binding|phosphatase binding|molecular adaptor activity|mitochondrial fusion|inner mitochondrial membrane organization|cristae formation","organelle|mitochondrion|nucleus|molecular adaptor activity|mitochondrion organization|membrane organization","",211197,ENSMUST00000066379,"",regulatory_region_variant,"",tsl1 (assigned to previous version 10),1,principal1,-1,"","","",ENSMUSR00000432804,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant|upstream_gene_variant",6,32800952,MGI:1913325,Chchd3,within coordinates of,SNP,C/T,T,C,C,,"","","","","",
6,32801083,32801083,1,+,-7.44000005722046,rs30163642,ENSMUSG00000053768,Chchd3,embryonic lethality before implantation complete penetrance,"mitochondrion|MICOS complex|membrane|nucleus|cytoplasm|mitochondrial inner membrane|protein binding|phosphatase binding|molecular adaptor activity|mitochondrial fusion|inner mitochondrial membrane organization|cristae formation","organelle|mitochondrion|nucleus|molecular adaptor activity|mitochondrion organization|membrane organization","",211197,ENSMUST00000066379,"",regulatory_region_variant,"",tsl1 (assigned to previous version 10),1,principal1,-1,"","","",ENSMUSR00000432804,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant|upstream_gene_variant",6,32801083,MGI:1913325,Chchd3,within coordinates of,SNP,A/G,A,G,G,,"","","","","",
6,32940411,32940411,1,+,-5.59000015258789,rs30667081,ENSMUSG00000053768,Chchd3,embryonic lethality before implantation complete penetrance,"mitochondrion|MICOS complex|membrane|nucleus|cytoplasm|mitochondrial inner membrane|protein binding|phosphatase binding|molecular adaptor activity|mitochondrial fusion|inner mitochondrial membrane organization|cristae formation","organelle|mitochondrion|nucleus|molecular adaptor activity|mitochondrion organization|membrane organization","",211197,"ENSMUST00000066379|ENSMUST00000115091","",regulatory_region_variant,"","tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 1)",1,"principal1|",-1,"","","",ENSMUSR00000854265,"","intron_variant|NMD_transcript_variant",6,32940411,MGI:1913325,Chchd3,within coordinates of,SNP,A/G,G,A,A,,"","","","","",
6,32955040,32955040,1,+,-6.6100001335144,rs30460176,ENSMUSG00000053768,Chchd3,embryonic lethality before implantation complete penetrance,"mitochondrion|MICOS complex|membrane|nucleus|cytoplasm|mitochondrial inner membrane|protein binding|phosphatase binding|molecular adaptor activity|mitochondrial fusion|inner mitochondrial membrane organization|cristae formation","organelle|mitochondrion|nucleus|molecular adaptor activity|mitochondrion organization|membrane organization","",211197,"ENSMUST00000066379|ENSMUST00000115091","",regulatory_region_variant,TF_binding_site_variant,"tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 1)",1,"principal1|",-1,"","","ENSPFM0036|ENSPFM0054",ENSMUSR00000224967,"","intron_variant|NMD_transcript_variant",6,32955040,MGI:1913325,Chchd3,within coordinates of,SNP,C/T,T,C,C,,"","","","","",
7,115135228,115135228,1,+,-16.8999996185303,rs32294718,ENSMUSG00000051910,Sox6,"abnormal sternum morphology|decreased body size|neonatal lethality incomplete penetrance|perinatal lethality incomplete penetrance|postnatal lethality complete penetrance|respiratory distress|respiratory failure","DNA binding|regulation of DNA-templated transcription|nucleus|transcription cis-regulatory region binding|DNA-binding transcription factor activity|protein homodimerization activity|brain development|positive regulation of chondrocyte differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|negative regulation of cardiac muscle cell differentiation|positive regulation of mesenchymal stem cell differentiation|nucleoplasm|in utero embryonic development|sequence-specific DNA binding|protein binding|positive regulation of transcription by RNA polymerase II|gene expression|erythrocyte differentiation|post-embryonic development|regulation of gene expression|negative regulation of transcription by RNA polymerase II|cell morphogenesis|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cartilage development|oligodendrocyte differentiation|regulation of DNA-binding transcription factor activity|cytoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|cell differentiation|positive regulation of DNA-templated transcription|hemopoiesis|negative regulation of DNA-templated transcription|cis-regulatory region sequence-specific DNA binding|astrocyte differentiation|transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|central nervous system development|cardiac muscle cell differentiation|cell fate commitment|erythrocyte development|chondrocyte differentiation|DNA-binding transcription repressor activity|cartilage condensation|spinal cord oligodendrocyte cell differentiation|oligodendrocyte cell fate specification","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|anatomical structure development|cell differentiation|nucleoplasm|immune system process","|R-MMU-162582|R-MMU-195721|R-MMU-201681|R-MMU-3769402",203410,"ENSMUST00000072804|ENSMUST00000106612|ENSMUST00000166207|ENSMUST00000169129|ENSMUST00000205405","",regulatory_region_variant,TF_binding_site_variant,"tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 7)|tsl1 (assigned to previous version 2)|tsl5 (assigned to previous version 1)",1,"principal4||alternative1",-1,"","","ENSPFM0012|ENSPFM0071|ENSPFM0013|ENSPFM0010|ENSPFM0007|ENSPFM0047|ENSPFM0026|ENSPFM0015",ENSMUSR00000864183,"","intron_variant|non_coding_transcript_variant|downstream_gene_variant",7,115135228,MGI:98368,Sox6,within coordinates of,SNP,C/T,C,T,T,,"","","","","",
7,115135342,115135342,1,+,-6.8899998664856,rs31185504,ENSMUSG00000051910,Sox6,"abnormal sternum morphology|decreased body size|neonatal lethality incomplete penetrance|perinatal lethality incomplete penetrance|postnatal lethality complete penetrance|respiratory distress|respiratory failure","DNA binding|regulation of DNA-templated transcription|nucleus|transcription cis-regulatory region binding|DNA-binding transcription factor activity|protein homodimerization activity|brain development|positive regulation of chondrocyte differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|negative regulation of cardiac muscle cell differentiation|positive regulation of mesenchymal stem cell differentiation|nucleoplasm|in utero embryonic development|sequence-specific DNA binding|protein binding|positive regulation of transcription by RNA polymerase II|gene expression|erythrocyte differentiation|post-embryonic development|regulation of gene expression|negative regulation of transcription by RNA polymerase II|cell morphogenesis|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cartilage development|oligodendrocyte differentiation|regulation of DNA-binding transcription factor activity|cytoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|cell differentiation|positive regulation of DNA-templated transcription|hemopoiesis|negative regulation of DNA-templated transcription|cis-regulatory region sequence-specific DNA binding|astrocyte differentiation|transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|central nervous system development|cardiac muscle cell differentiation|cell fate commitment|erythrocyte development|chondrocyte differentiation|DNA-binding transcription repressor activity|cartilage condensation|spinal cord oligodendrocyte cell differentiation|oligodendrocyte cell fate specification","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|anatomical structure development|cell differentiation|nucleoplasm|immune system process","|R-MMU-162582|R-MMU-195721|R-MMU-201681|R-MMU-3769402",203410,"ENSMUST00000072804|ENSMUST00000106612|ENSMUST00000166207|ENSMUST00000169129|ENSMUST00000205405","",regulatory_region_variant,TF_binding_site_variant,"tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 7)|tsl1 (assigned to previous version 2)|tsl5 (assigned to previous version 1)",1,"principal4||alternative1",-1,"","",ENSPFM0020,ENSMUSR00000864183,"","intron_variant|non_coding_transcript_variant|downstream_gene_variant",7,115135342,MGI:98368,Sox6,within coordinates of,SNP,A/C,C,A,A,,"","","","","",
7,115329829,115329829,1,+,-6.1399998664856,rs31882609,ENSMUSG00000051910,Sox6,"abnormal sternum morphology|decreased body size|neonatal lethality incomplete penetrance|perinatal lethality incomplete penetrance|postnatal lethality complete penetrance|respiratory distress|respiratory failure","DNA binding|regulation of DNA-templated transcription|nucleus|transcription cis-regulatory region binding|DNA-binding transcription factor activity|protein homodimerization activity|brain development|positive regulation of chondrocyte differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|negative regulation of cardiac muscle cell differentiation|positive regulation of mesenchymal stem cell differentiation|nucleoplasm|in utero embryonic development|sequence-specific DNA binding|protein binding|positive regulation of transcription by RNA polymerase II|gene expression|erythrocyte differentiation|post-embryonic development|regulation of gene expression|negative regulation of transcription by RNA polymerase II|cell morphogenesis|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cartilage development|oligodendrocyte differentiation|regulation of DNA-binding transcription factor activity|cytoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|cell differentiation|positive regulation of DNA-templated transcription|hemopoiesis|negative regulation of DNA-templated transcription|cis-regulatory region sequence-specific DNA binding|astrocyte differentiation|transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|central nervous system development|cardiac muscle cell differentiation|cell fate commitment|erythrocyte development|chondrocyte differentiation|DNA-binding transcription repressor activity|cartilage condensation|spinal cord oligodendrocyte cell differentiation|oligodendrocyte cell fate specification","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|anatomical structure development|cell differentiation|nucleoplasm|immune system process","|R-MMU-162582|R-MMU-195721|R-MMU-201681|R-MMU-3769402",203410,"ENSMUST00000072804|ENSMUST00000106612|ENSMUST00000166207|ENSMUST00000169129|ENSMUST00000205405","",regulatory_region_variant,TF_binding_site_variant,"tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 7)|tsl1 (assigned to previous version 2)|tsl5 (assigned to previous version 1)",1,"principal4||alternative1",-1,"","","ENSPFM0057|ENSPFM0033|ENSPFM0036|ENSPFM0055|ENSPFM0064|ENSPFM0076",ENSMUSR00000722449,"","intron_variant|non_coding_transcript_variant",7,115329829,MGI:98368,Sox6,within coordinates of,SNP,C/T,C,T,T,,"","","","","",
7,115329897,115329897,1,+,-7.65000009536743,rs32335293,ENSMUSG00000051910,Sox6,"abnormal sternum morphology|decreased body size|neonatal lethality incomplete penetrance|perinatal lethality incomplete penetrance|postnatal lethality complete penetrance|respiratory distress|respiratory failure","DNA binding|regulation of DNA-templated transcription|nucleus|transcription cis-regulatory region binding|DNA-binding transcription factor activity|protein homodimerization activity|brain development|positive regulation of chondrocyte differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|negative regulation of cardiac muscle cell differentiation|positive regulation of mesenchymal stem cell differentiation|nucleoplasm|in utero embryonic development|sequence-specific DNA binding|protein binding|positive regulation of transcription by RNA polymerase II|gene expression|erythrocyte differentiation|post-embryonic development|regulation of gene expression|negative regulation of transcription by RNA polymerase II|cell morphogenesis|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cartilage development|oligodendrocyte differentiation|regulation of DNA-binding transcription factor activity|cytoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|cell differentiation|positive regulation of DNA-templated transcription|hemopoiesis|negative regulation of DNA-templated transcription|cis-regulatory region sequence-specific DNA binding|astrocyte differentiation|transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|central nervous system development|cardiac muscle cell differentiation|cell fate commitment|erythrocyte development|chondrocyte differentiation|DNA-binding transcription repressor activity|cartilage condensation|spinal cord oligodendrocyte cell differentiation|oligodendrocyte cell fate specification","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|anatomical structure development|cell differentiation|nucleoplasm|immune system process","|R-MMU-162582|R-MMU-195721|R-MMU-201681|R-MMU-3769402",203410,"ENSMUST00000072804|ENSMUST00000106612|ENSMUST00000166207|ENSMUST00000169129|ENSMUST00000205405","",regulatory_region_variant,TF_binding_site_variant,"tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 7)|tsl1 (assigned to previous version 2)|tsl5 (assigned to previous version 1)",1,"principal4||alternative1",-1,"","","ENSPFM0045|ENSPFM0074",ENSMUSR00000722449,"","intron_variant|non_coding_transcript_variant",7,115329897,MGI:98368,Sox6,within coordinates of,SNP,C/T,C,T,T,,"","","","","",
7,115332349,115332349,1,+,-6.78999996185303,rs31407703,ENSMUSG00000051910,Sox6,"abnormal sternum morphology|decreased body size|neonatal lethality incomplete penetrance|perinatal lethality incomplete penetrance|postnatal lethality complete penetrance|respiratory distress|respiratory failure","DNA binding|regulation of DNA-templated transcription|nucleus|transcription cis-regulatory region binding|DNA-binding transcription factor activity|protein homodimerization activity|brain development|positive regulation of chondrocyte differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|negative regulation of cardiac muscle cell differentiation|positive regulation of mesenchymal stem cell differentiation|nucleoplasm|in utero embryonic development|sequence-specific DNA binding|protein binding|positive regulation of transcription by RNA polymerase II|gene expression|erythrocyte differentiation|post-embryonic development|regulation of gene expression|negative regulation of transcription by RNA polymerase II|cell morphogenesis|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cartilage development|oligodendrocyte differentiation|regulation of DNA-binding transcription factor activity|cytoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|cell differentiation|positive regulation of DNA-templated transcription|hemopoiesis|negative regulation of DNA-templated transcription|cis-regulatory region sequence-specific DNA binding|astrocyte differentiation|transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|central nervous system development|cardiac muscle cell differentiation|cell fate commitment|erythrocyte development|chondrocyte differentiation|DNA-binding transcription repressor activity|cartilage condensation|spinal cord oligodendrocyte cell differentiation|oligodendrocyte cell fate specification","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|anatomical structure development|cell differentiation|nucleoplasm|immune system process","|R-MMU-162582|R-MMU-195721|R-MMU-201681|R-MMU-3769402",203410,"ENSMUST00000072804|ENSMUST00000106612|ENSMUST00000166207|ENSMUST00000169129|ENSMUST00000205405","",regulatory_region_variant,TF_binding_site_variant,"tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 7)|tsl1 (assigned to previous version 2)|tsl5 (assigned to previous version 1)",1,"principal4||alternative1",-1,"","","ENSPFM0058|ENSPFM0030",ENSMUSR00000864201,"","intron_variant|non_coding_transcript_variant",7,115332349,MGI:98368,Sox6,within coordinates of,SNP,C/T,T,C,C,,"","","","","",
7,115351369,115351369,1,+,-5.3600001335144,rs31935223,ENSMUSG00000051910,Sox6,"abnormal sternum morphology|decreased body size|neonatal lethality incomplete penetrance|perinatal lethality incomplete penetrance|postnatal lethality complete penetrance|respiratory distress|respiratory failure","DNA binding|regulation of DNA-templated transcription|nucleus|transcription cis-regulatory region binding|DNA-binding transcription factor activity|protein homodimerization activity|brain development|positive regulation of chondrocyte differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|negative regulation of cardiac muscle cell differentiation|positive regulation of mesenchymal stem cell differentiation|nucleoplasm|in utero embryonic development|sequence-specific DNA binding|protein binding|positive regulation of transcription by RNA polymerase II|gene expression|erythrocyte differentiation|post-embryonic development|regulation of gene expression|negative regulation of transcription by RNA polymerase II|cell morphogenesis|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cartilage development|oligodendrocyte differentiation|regulation of DNA-binding transcription factor activity|cytoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|cell differentiation|positive regulation of DNA-templated transcription|hemopoiesis|negative regulation of DNA-templated transcription|cis-regulatory region sequence-specific DNA binding|astrocyte differentiation|transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|central nervous system development|cardiac muscle cell differentiation|cell fate commitment|erythrocyte development|chondrocyte differentiation|DNA-binding transcription repressor activity|cartilage condensation|spinal cord oligodendrocyte cell differentiation|oligodendrocyte cell fate specification","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|anatomical structure development|cell differentiation|nucleoplasm|immune system process","|R-MMU-162582|R-MMU-195721|R-MMU-201681|R-MMU-3769402",203410,"ENSMUST00000072804|ENSMUST00000106612|ENSMUST00000166207|ENSMUST00000169129|ENSMUST00000205405","",regulatory_region_variant,"","tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 7)|tsl1 (assigned to previous version 2)|tsl5 (assigned to previous version 1)",1,"principal4||alternative1",-1,"","","",ENSMUSR00000449126,"","intron_variant|non_coding_transcript_variant",7,115351369,MGI:98368,Sox6,within coordinates of,SNP,A/G,G,A,A,,"","","","","",
7,115363125,115363125,1,+,-5.21999979019165,rs31793665,ENSMUSG00000051910,Sox6,"abnormal sternum morphology|decreased body size|neonatal lethality incomplete penetrance|perinatal lethality incomplete penetrance|postnatal lethality complete penetrance|respiratory distress|respiratory failure","DNA binding|regulation of DNA-templated transcription|nucleus|transcription cis-regulatory region binding|DNA-binding transcription factor activity|protein homodimerization activity|brain development|positive regulation of chondrocyte differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|negative regulation of cardiac muscle cell differentiation|positive regulation of mesenchymal stem cell differentiation|nucleoplasm|in utero embryonic development|sequence-specific DNA binding|protein binding|positive regulation of transcription by RNA polymerase II|gene expression|erythrocyte differentiation|post-embryonic development|regulation of gene expression|negative regulation of transcription by RNA polymerase II|cell morphogenesis|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cartilage development|oligodendrocyte differentiation|regulation of DNA-binding transcription factor activity|cytoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|cell differentiation|positive regulation of DNA-templated transcription|hemopoiesis|negative regulation of DNA-templated transcription|cis-regulatory region sequence-specific DNA binding|astrocyte differentiation|transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|central nervous system development|cardiac muscle cell differentiation|cell fate commitment|erythrocyte development|chondrocyte differentiation|DNA-binding transcription repressor activity|cartilage condensation|spinal cord oligodendrocyte cell differentiation|oligodendrocyte cell fate specification","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|anatomical structure development|cell differentiation|nucleoplasm|immune system process","|R-MMU-162582|R-MMU-195721|R-MMU-201681|R-MMU-3769402",203410,"ENSMUST00000072804|ENSMUST00000106612|ENSMUST00000166207|ENSMUST00000169129|ENSMUST00000205405","",regulatory_region_variant,TF_binding_site_variant,"tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 7)|tsl1 (assigned to previous version 2)|tsl5 (assigned to previous version 1)",1,"principal4||alternative1",-1,"","","ENSPFM0031|ENSPFM0003",ENSMUSR00000864203,"","intron_variant|non_coding_transcript_variant",7,115363125,MGI:98368,Sox6,within coordinates of,SNP,C/T,T,C,C,,"","","","","",
7,115394974,115394974,1,+,-6.11999988555908,rs31102161,ENSMUSG00000051910,Sox6,"abnormal sternum morphology|decreased body size|neonatal lethality incomplete penetrance|perinatal lethality incomplete penetrance|postnatal lethality complete penetrance|respiratory distress|respiratory failure","DNA binding|regulation of DNA-templated transcription|nucleus|transcription cis-regulatory region binding|DNA-binding transcription factor activity|protein homodimerization activity|brain development|positive regulation of chondrocyte differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|negative regulation of cardiac muscle cell differentiation|positive regulation of mesenchymal stem cell differentiation|nucleoplasm|in utero embryonic development|sequence-specific DNA binding|protein binding|positive regulation of transcription by RNA polymerase II|gene expression|erythrocyte differentiation|post-embryonic development|regulation of gene expression|negative regulation of transcription by RNA polymerase II|cell morphogenesis|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cartilage development|oligodendrocyte differentiation|regulation of DNA-binding transcription factor activity|cytoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|cell differentiation|positive regulation of DNA-templated transcription|hemopoiesis|negative regulation of DNA-templated transcription|cis-regulatory region sequence-specific DNA binding|astrocyte differentiation|transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|central nervous system development|cardiac muscle cell differentiation|cell fate commitment|erythrocyte development|chondrocyte differentiation|DNA-binding transcription repressor activity|cartilage condensation|spinal cord oligodendrocyte cell differentiation|oligodendrocyte cell fate specification","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|anatomical structure development|cell differentiation|nucleoplasm|immune system process","|R-MMU-162582|R-MMU-195721|R-MMU-201681|R-MMU-3769402",203410,"ENSMUST00000072804|ENSMUST00000106612|ENSMUST00000166207|ENSMUST00000169129|ENSMUST00000205405","",regulatory_region_variant,"","tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 7)|tsl1 (assigned to previous version 2)|tsl5 (assigned to previous version 1)",1,"principal4||alternative1",-1,Fine mapping of QTL for prepulse inhibition in LG/J and SM/J mice using F(2) and advanced intercross lines.,"","",ENSMUSR00000722461,"","intron_variant|non_coding_transcript_variant",7,115394974,MGI:98368,Sox6,within coordinates of,SNP,C/T,T,C,C,,"","","","","",
7,115406842,115406842,1,+,-6.53000020980835,rs32272609,ENSMUSG00000051910,Sox6,"abnormal sternum morphology|decreased body size|neonatal lethality incomplete penetrance|perinatal lethality incomplete penetrance|postnatal lethality complete penetrance|respiratory distress|respiratory failure","DNA binding|regulation of DNA-templated transcription|nucleus|transcription cis-regulatory region binding|DNA-binding transcription factor activity|protein homodimerization activity|brain development|positive regulation of chondrocyte differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|negative regulation of cardiac muscle cell differentiation|positive regulation of mesenchymal stem cell differentiation|nucleoplasm|in utero embryonic development|sequence-specific DNA binding|protein binding|positive regulation of transcription by RNA polymerase II|gene expression|erythrocyte differentiation|post-embryonic development|regulation of gene expression|negative regulation of transcription by RNA polymerase II|cell morphogenesis|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cartilage development|oligodendrocyte differentiation|regulation of DNA-binding transcription factor activity|cytoplasm|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|cell differentiation|positive regulation of DNA-templated transcription|hemopoiesis|negative regulation of DNA-templated transcription|cis-regulatory region sequence-specific DNA binding|astrocyte differentiation|transcription regulator complex|DNA-binding transcription repressor activity, RNA polymerase II-specific|central nervous system development|cardiac muscle cell differentiation|cell fate commitment|erythrocyte development|chondrocyte differentiation|DNA-binding transcription repressor activity|cartilage condensation|spinal cord oligodendrocyte cell differentiation|oligodendrocyte cell fate specification","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|anatomical structure development|cell differentiation|nucleoplasm|immune system process","|R-MMU-162582|R-MMU-195721|R-MMU-201681|R-MMU-3769402",203410,"ENSMUST00000072804|ENSMUST00000106612|ENSMUST00000166207|ENSMUST00000169129|ENSMUST00000205405","",regulatory_region_variant,"","tsl1 (assigned to previous version 10)|tsl1 (assigned to previous version 7)|tsl1 (assigned to previous version 2)|tsl5 (assigned to previous version 1)",1,"principal4||alternative1",-1,"","","",ENSMUSR00000864207,"","intron_variant|non_coding_transcript_variant",7,115406842,MGI:98368,Sox6,within coordinates of,SNP,C/G,G,C,C,,"","","","","",
7,132608592,132608592,1,+,-5.17999982833862,rs32074957,ENSMUSG00000030849|ENSMUSG00000030970,Fgfr2|Ctbp2,"abnormal Rathke's pouch apoptosis|abnormal Rathke's pouch development|abnormal adrenal gland development|abnormal apical ectodermal ridge morphology|abnormal appendicular skeleton morphology|abnormal axial skeleton morphology|abnormal basicranium morphology|abnormal basisphenoid bone morphology|abnormal bone ossification|abnormal brain morphology|abnormal branching involved in seminal vesicle morphogenesis|abnormal bronchiole morphology|abnormal cecum development|abnormal cerebral hemisphere morphology|abnormal chondrocyte morphology|abnormal clavicle morphology|abnormal cochlea morphology|abnormal cochlear sensory epithelium morphology|abnormal conotruncal ridge morphology|abnormal coronal suture morphology|abnormal corpus callosum morphology|abnormal cranial cartilage development|abnormal cranial cartilage morphology|abnormal cranial synchondrosis|abnormal craniofacial morphology|abnormal cranium morphology|abnormal decidualization|abnormal dermis papillary layer morphology|abnormal developmental patterning|abnormal digestive system morphology|abnormal ear development|abnormal egg cylinder morphology|abnormal embryo development|abnormal endochondral bone ossification|abnormal endoderm development|abnormal endolymphatic duct morphology|abnormal epidermal layer morphology|abnormal epidermis stratum basale morphology|abnormal epidermis stratum corneum morphology|abnormal facial morphology|abnormal frontal bone morphology|abnormal hair follicle development|abnormal hair follicle morphology|abnormal head morphology|abnormal head shape|abnormal heart development|abnormal heart ventricle morphology|abnormal ilium morphology|abnormal interventricular groove morphology|abnormal intestinal glucose absorption|abnormal ischium morphology|abnormal keratinocyte morphology|abnormal kidney cortex morphology|abnormal kidney development|abnormal lateral nasal gland morphology|abnormal left posterior bundle morphology|abnormal limb development|abnormal liver development|abnormal long bone epiphyseal ossification zone morphology|abnormal long bone epiphyseal plate proliferative zone|abnormal long bone epiphysis morphology|abnormal lung development|abnormal lung morphology|abnormal mammary gland bud morphology|abnormal mammary placode morphology|abnormal membranous labyrinth morphology|abnormal midface morphology|abnormal nasal bone morphology|abnormal nasal capsule morphology|abnormal nasal gland morphology|abnormal nasal septum cartilage morphology|abnormal nasomaxillary suture morphology|abnormal neurocranium morphology|abnormal osteoblast physiology|abnormal osteoblast proliferation|abnormal otic capsule morphology|abnormal otic vesicle development|abnormal palatal shelf fusion at midline|abnormal palate development|abnormal palate morphology|abnormal palatine bone horizontal plate morphology|abnormal palatine bone morphology|abnormal pancreas development|abnormal pelvic girdle bone morphology|abnormal perineum morphology|abnormal pituitary gland development|abnormal placenta development|abnormal placenta morphology|abnormal placenta vasculature|abnormal presphenoid bone morphology|abnormal prostate gland branching morphogenesis|abnormal pulmonary acinus morphology|abnormal pulmonary circulation|abnormal rectum morphology|abnormal respiration|abnormal right lung morphology|abnormal salivary gland morphology|abnormal scapula morphology|abnormal secondary palate development|abnormal semicircular canal morphology|abnormal seminal vesicle development|abnormal seminal vesicle morphology|abnormal seminal vesicle muscle layer morphology|abnormal skin morphology|abnormal sphenoid bone morphology|abnormal spongiotrophoblast layer morphology|abnormal sternebra morphology|abnormal sternum manubrium morphology|abnormal sternum morphology|abnormal sternum ossification|abnormal stomach glandular region morphology|abnormal stomach morphology|abnormal submandibular duct morphology|abnormal synaptic vesicle clustering|abnormal synaptic vesicle number|abnormal synchondrosis|abnormal thymus development|abnormal tongue morphology|abnormal trabecula carnea morphology|abnormal trabecular bone morphology|abnormal tracheal cartilage morphology|abnormal trophoblast layer morphology|abnormal truncus arteriosus septation|abnormal umbilical cord morphology|abnormal urethra morphology|abnormal vertebrae morphology|abnormal vestibulocochlear ganglion morphology|abnormal vibrissa number|abnormal xiphoid process morphology|abnormal zygomatic arch morphology|absent Rathke's pouch|absent acromion|absent adenohypophysis|absent apical ectodermal ridge|absent blastocoele|absent exorbital lacrimal gland|absent eyelids|absent forelimb|absent hindlimb|absent hypodermis muscle layer|absent lacrimal glands|absent limb buds|absent limbs|absent lungs|absent mammary gland|absent palatal rugae|absent placental labyrinth|absent presphenoid bone|absent primitive endoderm|absent pubis|absent pulmonary artery|absent pulmonary vein|absent rectum|absent submandibular gland|absent teeth|absent thyroid gland|acanthosis|arrest of tooth development|atrium hypoplasia|caudal vertebral fusion|cecal atresia|cervical vertebral fusion|cleft palate|cleft secondary palate|conotruncal ridge hypoplasia|curly tail|decreased birth body size|decreased body size|decreased body weight|decreased brain size|decreased cranium height|decreased cranium length|decreased embryo size|decreased fetal size|decreased hair follicle number|decreased molar number|decreased nephron number|decreased osteoblast cell number|decreased palatal length|decreased prostate gland duct number|decreased renal glomerulus number|decreased skin pigmentation|decreased width of hypertrophic chondrocyte zone|delayed bone ossification|delayed cranial suture closure|delayed intramembranous bone ossification|dilated distal convoluted tubule|dilated proximal convoluted tubule|domed cranium|double outlet right ventricle|embryonic growth retardation|embryonic lethality between implantation and somite formation complete penetrance|embryonic lethality during organogenesis complete penetrance|enhanced osteoblast differentiation|enlarged allantois|enlarged fourth ventricle|enlarged lateral ventricles|epidermal hyperplasia|epidermis stratum granulosum hyperplasia|epidermis stratum spinosum hyperplasia|exophthalmos|eyelids open at birth|failure of chorioallantoic fusion|fused joints|fused tracheal cartilage rings|hypoglycemia|hypospadia|impaired branching involved in trachea morphogenesis|impaired lung alveolus development|impaired lung lobe morphogenesis|increased cranium height|increased cranium width|increased osteoblast cell number|increased prostate gland weight|increased trophoblast giant cell number|inner cell mass degeneration|inner ear cyst|lethality throughout fetal growth and development|long incisors|malocclusion|midface hypoplasia|muscular ventricular septal defect|neonatal lethality|neonatal lethality complete penetrance|no abnormal phenotype detected|ocular hypertelorism|overriding aortic valve|palatal shelf fusion with tongue or mandible|palatal shelves fail to meet at midline|perimembraneous ventricular septal defect|perinatal lethality complete penetrance|perineal hypospadia|postnatal growth retardation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|premature coronal suture closure|premature cranial suture closure|premature death|premature intramembranous bone ossification|premature squamoparietal suture closure|premature zygomaticomaxillary suture closure|primary sex reversal|pulmonary hypoplasia|respiratory distress|respiratory failure|shallow orbits|short basicranium|short face|short maxilla|short rostral-caudal axis|short snout|shortened head|slow postnatal weight gain|small frontal bone|small kidney|small lung|small otic capsule|small otic vesicle|small pancreas|small parietal bone|small scapula|small stomach|split sternal manubrium|split sternum|split xiphoid process|submandibular gland hypoplasia|syndactyly|thick epidermis|thick nasal septum|thin dermal layer|thin epidermis|thin skin|thin ventricular wall|tongue ankylosis|translucent skin|ventricular hypoplasia|vertebral fusion|wide cranial sutures"|"decreased exploration in new environment|increased cornea thickness|prenatal lethality prior to heart atrial septation|preweaning lethality complete penetrance|abnormal embryonic neuroepithelium morphology|abnormal forebrain development|abnormal heart tube morphology|abnormal midbrain development|abnormal placenta development|abnormal placental labyrinth vasculature morphology|absent vitelline blood vessels|decreased embryo size|decreased embryonic neuroepithelium thickness|distended pericardium|lethality throughout fetal growth and development complete penetrance","integral component of membrane|ATP binding|protein phosphorylation|protein kinase activity|protein tyrosine kinase activity|fibroblast growth factor receptor activity|positive regulation of cell population proliferation|fibroblast growth factor receptor signaling pathway|membrane|transferase activity|plasma membrane|nucleotide binding|kinase activity|phosphorylation|transmembrane receptor protein tyrosine kinase activity|peptidyl-tyrosine phosphorylation|fibroblast growth factor binding|protein homodimerization activity|epithelial to mesenchymal transition|endochondral bone growth|positive regulation of phospholipase activity|negative regulation of keratinocyte proliferation|response to lipopolysaccharide|wound healing|positive regulation of MAPK cascade|cellular response to fibroblast growth factor stimulus|response to ethanol|protein autophosphorylation|mesodermal cell differentiation|positive regulation of smooth muscle cell proliferation|embryonic cranial skeleton morphogenesis|negative regulation of epithelial cell proliferation|cellular response to retinoic acid|cellular response to transforming growth factor beta stimulus|nucleus|cytoplasm|cell cortex|cell surface|collagen-containing extracellular matrix"|"NAD binding|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor|transcription corepressor activity|cellular response to leukemia inhibitory factor|nucleus|protein binding|positive regulation of transcription by RNA polymerase II|synapse|protein-containing complex binding|chromatin binding|regulation of transcription by RNA polymerase II|oxidoreductase activity|glutamatergic synapse|cell differentiation|identical protein binding|negative regulation of DNA-templated transcription|protein kinase binding|transcription coactivator activity|cytosol|white fat cell differentiation|transcription repressor complex|nuclear retinoic acid receptor binding|transcription corepressor binding|GABA-ergic synapse|photoreceptor ribbon synapse|presynaptic active zone cytoplasmic component|presynaptic cytosol|positive regulation of chromatin binding|ribbon synapse|transcription coregulator binding|DNA-binding transcription factor binding|structural constituent of presynaptic active zone|maintenance of presynaptic active zone structure|synaptic vesicle docking|positive regulation of retinoic acid receptor signaling pathway","protein modification process|catalytic activity|transferase activity|catalytic activity, acting on a protein|molecular transducer activity|signaling|plasma membrane|anatomical structure development|cell differentiation|wound healing|organelle|nucleus|extracellular matrix|external encapsulating structure"|"oxidoreductase activity|catalytic activity|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus|cell differentiation|cytosol|structural molecule activity|cell junction organization|signaling|vesicle-mediated transport","",""|198962,""|"ENSMUST00000033269|ENSMUST00000165457|ENSMUST00000166439|ENSMUST00000169570","",""|regulatory_region_variant,""|TF_binding_site_variant,""|"tsl1 (assigned to previous version 14)|tsl1 (assigned to previous version 1)|tsl1 (assigned to previous version 7)|tsl5 (assigned to previous version 7)",""|1,""|"principal1|",-1,"","",ENSPFM0024,ENSMUSR00000450697,"",intron_variant|"NMD_transcript_variant|intron_variant",7,132608592,MGI:1201686,Ctbp2,within coordinates of,SNP,C/T,C,C,T,,"","","","","",
7,4526346,4526346,1,+,-5.5,rs32422596,ENSMUSG00000035458|ENSMUSG00000055809,Tnni3|Dnaaf3,"abnormal cardiovascular system physiology|abnormal lung vasculature morphology|abnormal myocardial fiber morphology|abnormal myocardium layer morphology|abnormal sarcomere morphology|cardiac interstitial fibrosis|congestive heart failure|increased heart weight|lethargy|postnatal lethality complete penetrance|preweaning lethality complete penetrance|respiratory distress|thick interventricular septum|thick ventricular wall"|"abnormal body wall morphology|preweaning lethality incomplete penetrance|abdominal situs ambiguus|abdominal situs inversus|abnormal aortic arch morphology|abnormal inferior vena cava morphology|abnormal liver morphology|abnormal vein morphology|abnormal vertebral column morphology|dextrocardia|dual inferior vena cava|heterotaxia|immotile respiratory cilia|increased total body fat amount|left pulmonary isomerism|right aortic arch|situs inversus totalis","troponin complex|heart development|cytoplasm|actin binding|molecular function inhibitor activity|regulation of system process|vasculogenesis|protein kinase binding|calcium channel inhibitor activity|myofibril|contractile fiber|negative regulation of ATP-dependent activity|cellular calcium ion homeostasis|protein domain specific binding|actin filament binding|sarcomere|striated muscle contraction|cardiac myofibril|cardiac muscle contraction|muscle contraction|regulation of smooth muscle contraction|regulation of muscle contraction|regulation of cardiac muscle contraction by calcium ion signaling|heart contraction|calcium-dependent protein binding|skeletal muscle contraction|troponin T binding|ventricular cardiac muscle tissue morphogenesis|cardiac Troponin complex|troponin C binding|regulation of systemic arterial blood pressure by ischemic conditions"|"axonemal dynein complex assembly|molecular_function|cellular_component|motile cilium assembly|heart development|cytoplasm|cell projection organization|dynein axonemal particle|determination of left/right symmetry","organelle|cytoskeleton|anatomical structure development|cytoskeletal protein binding|molecular function regulator activity|cell differentiation|metal ion homeostasis|muscle system process|circulatory system process|signaling|nervous system process"|"cytoskeleton organization|protein-containing complex assembly|cilium organization|anatomical structure development|organelle","R-MMU-390522|R-MMU-397014|R-MMU-5576891|R-MMU-5578775|"|"",204266|242677,""|ENSMUST00000094897,""|"tolerated - low confidence|",""|regulatory_region_variant,"",""|tsl1 (assigned to previous version 4),""|1,""|principal1,-1,"",""|W/S,"",ENSMUSR00000711329,""|0.43,"upstream_gene_variant|intron_variant"|missense_variant,7,4526346,MGI:3588207,Dnaaf3,within coordinates of,SNP,C/G,G,G,C,,"","","","","",""
8,109515937,109515937,1,+,-7.51000022888184,rs31092298,ENSMUSG00000038872,Zfhx3,"abnormal circadian behavior|abnormal circadian behavior phase|abnormal circardian behavior entrainment|abnormal eating behavior|abnormal fertility/fecundity|advanced circadian behavior phase|arrhythmic circadian behavior persistence|decreased body size|decreased body weight|decreased growth hormone level|decreased locomotor activity|decreased thyroid-stimulating hormone level|no abnormal phenotype detected|postnatal lethality incomplete penetrance|premature death|prenatal lethality complete penetrance|shortened circadian behavior period","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleic acid binding|DNA-binding transcription factor activity, RNA polymerase II-specific|nucleus|RNA polymerase II cis-regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity, RNA polymerase II-specific|enzyme binding|negative regulation of transcription by RNA polymerase II|brain development|regulation of neuron differentiation|positive regulation of DNA-templated transcription|regulation of cell cycle|response to transforming growth factor beta|nucleoplasm|transcription regulator complex|cytoplasm|nuclear body","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus|anatomical structure development|cell differentiation|nucleoplasm","","","ENSMUST00000043896|ENSMUST00000220518","",regulatory_region_variant,"","tsl1 (assigned to previous version 9)|tsl5 (assigned to previous version 1)",1,principal1,1,"","","",ENSMUSR00000738777,"",intron_variant,8,109515937,MGI:99948,Zfhx3,within coordinates of,SNP,C/T,C,C,T,,"","","","","",
8,109572575,109572575,1,+,-5.67999982833862,rs31102803,ENSMUSG00000038872,Zfhx3,"abnormal circadian behavior|abnormal circadian behavior phase|abnormal circardian behavior entrainment|abnormal eating behavior|abnormal fertility/fecundity|advanced circadian behavior phase|arrhythmic circadian behavior persistence|decreased body size|decreased body weight|decreased growth hormone level|decreased locomotor activity|decreased thyroid-stimulating hormone level|no abnormal phenotype detected|postnatal lethality incomplete penetrance|premature death|prenatal lethality complete penetrance|shortened circadian behavior period","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleic acid binding|DNA-binding transcription factor activity, RNA polymerase II-specific|nucleus|RNA polymerase II cis-regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity, RNA polymerase II-specific|enzyme binding|negative regulation of transcription by RNA polymerase II|brain development|regulation of neuron differentiation|positive regulation of DNA-templated transcription|regulation of cell cycle|response to transforming growth factor beta|nucleoplasm|transcription regulator complex|cytoplasm|nuclear body","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|organelle|nucleus|anatomical structure development|cell differentiation|nucleoplasm","","","ENSMUST00000043896|ENSMUST00000220518","",regulatory_region_variant,"","tsl1 (assigned to previous version 9)|tsl5 (assigned to previous version 1)",1,principal1,1,"","","",ENSMUSR00000870391,"",intron_variant,8,109572575,MGI:99948,Zfhx3,within coordinates of,SNP,G/T,G,G,T,,"","","","","",
8,128187873,128187873,1,+,-5.3899998664856,rs33483124,ENSMUSG00000025812,Pard3,"abnormal optic disk morphology|abnormal retina morphology|decreased basophil cell number|decreased spleen weight|preweaning lethality complete penetrance|abnormal heart development|abnormal telencephalon development|atrium hypoplasia|edema|embryonic growth retardation|embryonic lethality during organogenesis complete penetrance|enlarged heart atrium|short tail|ventricular hypoplasia","protein binding|anchoring junction|cell cycle|endomembrane system|cell division|phosphatidylinositol-4,5-bisphosphate binding|phosphatidylinositol-3,4,5-trisphosphate binding|protein phosphatase binding|phosphatidylinositol-3-phosphate binding|identical protein binding|protein targeting to membrane|establishment or maintenance of epithelial cell apical/basal polarity|regulation of cellular localization|bicellular tight junction assembly|establishment of epithelial cell polarity|plasma membrane|cell-cell junction|bicellular tight junction|cell junction|protein-containing complex|neuronal cell body|axonal growth cone|PAR polarity complex|cytoplasm|membrane|cell cortex|apical plasma membrane|cytoskeleton|cell-cell adhesion|lipid binding|cell differentiation|microtubule cytoskeleton organization|cell adhesion|adherens junction|spindle|apical junction complex|centrosome localization|protein localization|Schmidt-Lanterman incisure|phosphatidylinositol binding|wound healing, spreading of cells|myelination in peripheral nervous system|positive regulation of myelination|establishment or maintenance of cell polarity|positive regulation of receptor internalization|apical constriction|regulation of actin filament-based process|lateral loop|establishment of cell polarity|negative regulation of peptidyl-threonine phosphorylation|establishment of centrosome localization|internode region of axon","lipid binding|intracellular protein transport|establishment or maintenance of cell polarity|cell junction organization|plasma membrane|organelle|cytoskeleton|cell adhesion|cell differentiation|cytoskeleton organization|anatomical structure development|wound healing|cell motility|nervous system process|vesicle-mediated transport|protein modification process","|R-MMU-162582|R-MMU-170834|R-MMU-9006936|R-MMU-1500931|R-MMU-421270|R-MMU-446728|R-MMU-2173791|R-MMU-420029","","ENSMUST00000026921|ENSMUST00000160272|ENSMUST00000162309|ENSMUST00000162665","",regulatory_region_variant,TF_binding_site_variant,"tsl1 (assigned to previous version 12)|tsl1 (assigned to previous version 7)",1,"alternative2|principal4|",1,"","","ENSPFM0048|ENSPFM0077",ENSMUSR00000460702,"","intron_variant|non_coding_transcript_variant",8,128187873,MGI:2135608,Pard3,within coordinates of,SNP,C/T,C,T,T,,"","","","","",""
8,73258334,73258334,1,+,-6.15999984741211,rs33199259,ENSMUSG00000045248,Med26,"","nucleus|regulation of transcription by RNA polymerase II|mediator complex|transcription coregulator activity|positive regulation of transcription elongation by RNA polymerase II|RNA polymerase II preinitiation complex assembly|positive regulation of transcription initiation by RNA polymerase II|nucleoplasm|core mediator complex|positive regulation of gene expression","organelle|nucleus|DNA-templated transcription|regulation of DNA-templated transcription|transcription regulator activity|protein-containing complex assembly|nucleoplasm","",214175,ENSMUST00000058534,"",regulatory_region_variant,"",tsl1 (assigned to previous version 6),1,principal1,-1,"","","",ENSMUSR00000868761,"",intron_variant,8,73258334,MGI:1917875,Med26,within coordinates of,SNP,C/T,C,C,T,,"","","","","",
8,88614826,88614826,1,+,-5.03999996185303,rs32653364,ENSMUSG00000045333,Zfp423,"decreased locomotor activity|increased circulating alkaline phosphatase level|persistence of hyaloid vascular system|preweaning lethality complete penetrance|abnormal Purkinje cell dendrite morphology|abnormal cerebellar cortex morphology|abnormal cerebellar granule cell precursor proliferation|abnormal cerebellar plate morphology|abnormal cerebellum development|abnormal cerebellum lateral hemisphere morphology|abnormal cerebellum morphology|abnormal cerebellum vermis morphology|abnormal choroid plexus morphology|abnormal corpus callosum morphology|abnormal food intake|abnormal forebrain morphology|abnormal gait|abnormal hippocampal commissure morphology|abnormal hippocampus morphology|abnormal interventricular foramen morphology|abnormal medulla oblongata morphology|abnormal motor coordination/ balance|abnormal nasal cavity morphology|abnormal olfactory bulb morphology|abnormal olfactory epithelium morphology|abnormal olfactory nerve morphology|abnormal telencephalon morphology|absent cerebellum|absent cerebellum vermis|absent corpus callosum|ataxia|cerebellum hypoplasia|cerebellum vermis hypoplasia|decreased Purkinje cell number|decreased body size|decreased body weight|decreased brain size|decreased hindbrain size|dehydration|dilated fourth ventricle|dilated lateral ventricle|ectopic Purkinje cell|enlarged fourth ventricle|enlarged lateral ventricles|lethality at weaning complete penetrance|lethality at weaning incomplete penetrance|neonatal lethality incomplete penetrance|no abnormal phenotype detected|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|premature death|reduced cerebellar foliation|small cerebellum|small olfactory bulb|small thalamus|tremors","nucleus|sequence-specific DNA binding|protein-containing complex binding|nucleoplasm|DNA binding|metal ion binding|regulation of transcription by RNA polymerase II|nervous system development|DNA-binding transcription factor activity, RNA polymerase II-specific|positive regulation of DNA-templated transcription|cell differentiation|protein binding|identical protein binding|Notch signaling pathway|negative regulation of DNA-templated transcription|negative regulation of cold-induced thermogenesis|cilium assembly|protein localization to cilium|positive regulation of BMP signaling pathway|cerebellar granule cell precursor proliferation|smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation|brown fat cell differentiation|white fat cell differentiation","organelle|nucleus|DNA binding|nucleoplasm|DNA-templated transcription|regulation of DNA-templated transcription|anatomical structure development|transcription regulator activity|cell differentiation|signaling|cilium organization","",220465,"ENSMUST00000052250|ENSMUST00000109655","",regulatory_region_variant,"","tsl1 (assigned to previous version 14)|tsl1 (assigned to previous version 8)",1,"|principal1",-1,"","","",ENSMUSR00000869448,"","intron_variant|non_coding_transcript_variant",8,88614826,MGI:1891217,Zfp423,within coordinates of,SNP,A/G,A,G,G,,"","","","","",""
9,100567497,100567497,1,+,-6.84999990463257,rs29884699,ENSMUSG00000037286,Stag1,"abnormal kidney morphology|abnormal lymph node morphology|abnormal placenta morphology|abnormal placenta vasculature|abnormal spleen morphology|blind uterus|edema|embryonic growth retardation|enlarged lymph nodes|enlarged spleen|increased circulating triglyceride level|microphthalmia|preweaning lethality complete penetrance|small kidney|small spleen|urinary bladder obstruction|abnormal bone mineralization|abnormal definitive hematopoiesis|abnormal kidney collecting duct morphology|abnormal mitosis|abnormal muscle morphology|abnormal renal glomerulus morphology|abnormal telomere morphology|abnormal tooth development|aneuploidy|decreased brown adipose tissue amount|decreased cell proliferation|decreased fetal size|decreased fibroblast proliferation|decreased hair follicle number|decreased hemoglobin content|decreased incidence of tumors by chemical induction|decreased total body fat amount|decreased tumor growth/size|delayed intramembranous bone ossification|embryonic lethality during organogenesis incomplete penetrance|increased carcinoma incidence|increased hepatocellular carcinoma incidence|increased histiocytic sarcoma incidence|increased lymphoma incidence|increased mean corpuscular volume|increased papilloma incidence|increased tumor incidence|kyphosis|lethality throughout fetal growth and development complete penetrance|premature aging|premature death|thin skin","chromatin binding|nuclear body|chromatin|nucleoplasm|nucleus|chromosome|cell cycle|cell division|chromosome segregation|mitotic spindle assembly|mitotic spindle pole|nuclear matrix|sister chromatid cohesion|cohesin complex|localization|chromosome, centromeric region","organelle|nucleus|nucleoplasm|chromosome|chromosome segregation|cytoskeleton organization|mitotic cell cycle|mitotic nuclear division|cytoskeleton","|R-MMU-392499|R-MMU-1640170|R-MMU-2555396|R-MMU-2990846|R-MMU-3108214|R-MMU-3108232|R-MMU-597592|R-MMU-68882|R-MMU-68886|R-MMU-69278|R-MMU-68877|R-MMU-2467813|R-MMU-2500257|R-MMU-69242|R-MMU-68884|R-MMU-2468052|R-MMU-2470946",203517,"ENSMUST00000123302|ENSMUST00000129269|ENSMUST00000138405|ENSMUST00000143816|ENSMUST00000146312|ENSMUST00000155108","",regulatory_region_variant,"",tsl1 (assigned to previous version 7),1,"|principal1",1,"","","",ENSMUSR00000754788,"","intron_variant|non_coding_transcript_variant|NMD_transcript_variant",9,100567497,MGI:1098658,Stag1,within coordinates of,SNP,A/T,T,T,A,,"","","","","",
9,106570517,106570517,1,+,-5.40000009536743,rs30376929,ENSMUSG00000040661,Rad54l2,"abnormal skin morphology|abnormal sternum morphology|embryonic lethality prior to organogenesis|enlarged urinary bladder|increased lean body mass|preweaning lethality complete penetrance|abnormal embryonic tissue morphology|abnormal neural tube morphology|decreased cell proliferation|decreased embryo size|decreased embryonic neuroepithelial cell proliferation|decreased fibroblast proliferation|embryonic growth retardation|embryonic lethality during organogenesis complete penetrance|increased apoptosis|increased fibroblast apoptosis|increased neural tube apoptosis","ATP binding|ATP-dependent chromatin remodeler activity|ATP hydrolysis activity|nucleus|DNA binding|nucleotide binding|chromatin remodeling","catalytic activity|catalytic activity, acting on DNA|ATP-dependent activity|chromatin organization|hydrolase activity|organelle|nucleus|DNA binding","","",ENSMUST00000046502,"tolerated - low confidence|",regulatory_region_variant,"",tsl1 (assigned to previous version 6),1,principal1,-1,"","V/I|","",ENSMUSR00000877194,0.26,"missense_variant|upstream_gene_variant",9,106570517,MGI:1933196,Rad54l2,within coordinates of,SNP,C/T,T,T,C,,"","","","","",
9,106655975,106655975,1,+,-5.1100001335144,rs30174517,ENSMUSG00000040661,Rad54l2,"abnormal skin morphology|abnormal sternum morphology|embryonic lethality prior to organogenesis|enlarged urinary bladder|increased lean body mass|preweaning lethality complete penetrance|abnormal embryonic tissue morphology|abnormal neural tube morphology|decreased cell proliferation|decreased embryo size|decreased embryonic neuroepithelial cell proliferation|decreased fibroblast proliferation|embryonic growth retardation|embryonic lethality during organogenesis complete penetrance|increased apoptosis|increased fibroblast apoptosis|increased neural tube apoptosis","ATP binding|ATP-dependent chromatin remodeler activity|ATP hydrolysis activity|nucleus|DNA binding|nucleotide binding|chromatin remodeling","catalytic activity|catalytic activity, acting on DNA|ATP-dependent activity|chromatin organization|hydrolase activity|organelle|nucleus|DNA binding","","",ENSMUST00000046502,"",regulatory_region_variant,TF_binding_site_variant,tsl1 (assigned to previous version 6),1,principal1,-1,"","",ENSPFM0027,ENSMUSR00000755664,"",intron_variant,9,106655975,MGI:1933196,Rad54l2,within coordinates of,SNP,C/G,C,C,G,,"","","","","",
9,68690334,68690334,1,+,-7.21999979019165,rs29732312,ENSMUSG00000032238,Rora,"increased circulating alkaline phosphatase level|preweaning lethality incomplete penetrance|Purkinje cell degeneration|abnormal Purkinje cell dendrite morphology|abnormal Purkinje cell differentiation|abnormal Purkinje cell morphology|abnormal brain interneuron morphology|abnormal brain morphology|abnormal cerebellar Purkinje cell layer|abnormal cerebellar foliation|abnormal cerebellar granule cell morphology|abnormal cerebellar granule layer morphology|abnormal cerebellar layer morphology|abnormal cerebellar molecular layer|abnormal cerebellum deep nucleus morphology|abnormal cerebellum external granule cell layer morphology|abnormal cerebellum morphology|abnormal cochlear VIII nucleus morphology|abnormal estrous cycle|abnormal excitatory postsynaptic currents|abnormal external female genitalia morphology|abnormal female reproductive system physiology|abnormal fertility/fecundity|abnormal gait|abnormal hormone level|abnormal immune system organ morphology|abnormal immune system physiology|abnormal inferior olivary complex morphology|abnormal limb posture|abnormal lipid homeostasis|abnormal lung compliance|abnormal macrophage physiology|abnormal maternal nurturing|abnormal motor capabilities/coordination/movement|abnormal motor learning|abnormal nervous system physiology|abnormal neuron proliferation|abnormal olfaction|abnormal olfactory bulb external plexiform layer morphology|abnormal olfactory bulb glomerular layer morphology|abnormal olfactory bulb granule cell layer morphology|abnormal olfactory bulb granule cell morphology|abnormal olfactory bulb internal plexiform layer morphology|abnormal olfactory bulb layer morphology|abnormal olfactory bulb mitral cell layer morphology|abnormal olfactory bulb morphology|abnormal olfactory bulb outer nerve layer morphology|abnormal radial glial cell morphology|abnormal respiratory mucosa morphology|abnormal sexual interaction|abnormal spatial learning|abnormal synaptic glutamate release|abnormal vasoconstriction|abnormal vasodilation|absent cerebellar granule cells|absent cerebellar granule layer|absent duvet hair|ataxia|atherosclerotic lesions|decreased Purkinje cell number|decreased aspartic acid level|decreased body size|decreased cerebellar granule cell number|decreased cerebellar granule cell precursor proliferation|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|decreased gamma-aminobutyric acid level|decreased grip strength|decreased locomotor activity|decreased mean systemic arterial blood pressure|decreased taurine level|delaminated Purkinje cell layer|delayed estrous cycle|ectopic Purkinje cell|ectopic cerebellar granule cells|hindlimb paralysis|impaired balance|impaired coordination|impaired limb coordination|impaired righting response|increased IgE level|increased angiogenesis|increased interleukin-1 secretion|increased noradrenaline level|increased susceptibility to atherosclerosis|lethality at weaning incomplete penetrance|limb grasping|lung inflammation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|prolonged estrus|prolonged metestrus|reduced cerebellar foliation|reduced female fertility|retarded hair growth|small cerebellum|small olfactory bulb|sparse hair|spleen atrophy|thin cerebellar granule layer|thin cerebellar molecular layer|thymus atrophy|tremors","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleus|DNA-binding transcription factor activity|sequence-specific DNA binding|nuclear receptor activity|cellular response to hypoxia|nucleolus|positive regulation of transcription by RNA polymerase II|cellular response to tumor necrosis factor|negative regulation of inflammatory response|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of DNA-templated transcription|regulation of gene expression|RNA polymerase II transcription regulatory region sequence-specific DNA binding|rhythmic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleoplasm|beta-catenin binding|circadian regulation of gene expression|transcription coregulator binding|cerebellar Purkinje cell differentiation|transcription coactivator binding|transcription corepressor binding|regulation of glucose metabolic process|regulation of macrophage activation|xenobiotic metabolic process|muscle cell differentiation|regulation of circadian rhythm|cholesterol homeostasis|regulation of smoothened signaling pathway|cellular response to interleukin-1|nitric oxide biosynthetic process|cerebellar granule cell precursor proliferation|cGMP metabolic process|positive regulation of vascular endothelial growth factor production|triglyceride homeostasis|intracellular receptor signaling pathway|positive regulation of circadian rhythm|oxysterol binding|ligand-activated transcription factor activity|regulation of steroid metabolic process|cellular response to sterol|negative regulation of fat cell differentiation|T-helper 17 cell differentiation|DNA-templated transcription","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|molecular transducer activity|signaling|nucleolus|inflammatory response|anatomical structure development|nucleoplasm|cell differentiation|carbohydrate metabolic process|immune system process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|lipid binding|lipid metabolic process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-597592|R-MMU-383280|R-MMU-4090294|",202956,ENSMUST00000034766,"",regulatory_region_variant,TF_binding_site_variant,tsl1 (assigned to previous version 13),1,"",1,"","",ENSPFM0060,ENSMUSR00000466281,"","intron_variant|NMD_transcript_variant",9,68690334,MGI:104661,Rora,within coordinates of,SNP,A/G,A,A,G,,"","","","","",""
9,68690471,68690471,1,+,-7.65000009536743,rs30220196,ENSMUSG00000032238,Rora,"increased circulating alkaline phosphatase level|preweaning lethality incomplete penetrance|Purkinje cell degeneration|abnormal Purkinje cell dendrite morphology|abnormal Purkinje cell differentiation|abnormal Purkinje cell morphology|abnormal brain interneuron morphology|abnormal brain morphology|abnormal cerebellar Purkinje cell layer|abnormal cerebellar foliation|abnormal cerebellar granule cell morphology|abnormal cerebellar granule layer morphology|abnormal cerebellar layer morphology|abnormal cerebellar molecular layer|abnormal cerebellum deep nucleus morphology|abnormal cerebellum external granule cell layer morphology|abnormal cerebellum morphology|abnormal cochlear VIII nucleus morphology|abnormal estrous cycle|abnormal excitatory postsynaptic currents|abnormal external female genitalia morphology|abnormal female reproductive system physiology|abnormal fertility/fecundity|abnormal gait|abnormal hormone level|abnormal immune system organ morphology|abnormal immune system physiology|abnormal inferior olivary complex morphology|abnormal limb posture|abnormal lipid homeostasis|abnormal lung compliance|abnormal macrophage physiology|abnormal maternal nurturing|abnormal motor capabilities/coordination/movement|abnormal motor learning|abnormal nervous system physiology|abnormal neuron proliferation|abnormal olfaction|abnormal olfactory bulb external plexiform layer morphology|abnormal olfactory bulb glomerular layer morphology|abnormal olfactory bulb granule cell layer morphology|abnormal olfactory bulb granule cell morphology|abnormal olfactory bulb internal plexiform layer morphology|abnormal olfactory bulb layer morphology|abnormal olfactory bulb mitral cell layer morphology|abnormal olfactory bulb morphology|abnormal olfactory bulb outer nerve layer morphology|abnormal radial glial cell morphology|abnormal respiratory mucosa morphology|abnormal sexual interaction|abnormal spatial learning|abnormal synaptic glutamate release|abnormal vasoconstriction|abnormal vasodilation|absent cerebellar granule cells|absent cerebellar granule layer|absent duvet hair|ataxia|atherosclerotic lesions|decreased Purkinje cell number|decreased aspartic acid level|decreased body size|decreased cerebellar granule cell number|decreased cerebellar granule cell precursor proliferation|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|decreased gamma-aminobutyric acid level|decreased grip strength|decreased locomotor activity|decreased mean systemic arterial blood pressure|decreased taurine level|delaminated Purkinje cell layer|delayed estrous cycle|ectopic Purkinje cell|ectopic cerebellar granule cells|hindlimb paralysis|impaired balance|impaired coordination|impaired limb coordination|impaired righting response|increased IgE level|increased angiogenesis|increased interleukin-1 secretion|increased noradrenaline level|increased susceptibility to atherosclerosis|lethality at weaning incomplete penetrance|limb grasping|lung inflammation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|prolonged estrus|prolonged metestrus|reduced cerebellar foliation|reduced female fertility|retarded hair growth|small cerebellum|small olfactory bulb|sparse hair|spleen atrophy|thin cerebellar granule layer|thin cerebellar molecular layer|thymus atrophy|tremors","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleus|DNA-binding transcription factor activity|sequence-specific DNA binding|nuclear receptor activity|cellular response to hypoxia|nucleolus|positive regulation of transcription by RNA polymerase II|cellular response to tumor necrosis factor|negative regulation of inflammatory response|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of DNA-templated transcription|regulation of gene expression|RNA polymerase II transcription regulatory region sequence-specific DNA binding|rhythmic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleoplasm|beta-catenin binding|circadian regulation of gene expression|transcription coregulator binding|cerebellar Purkinje cell differentiation|transcription coactivator binding|transcription corepressor binding|regulation of glucose metabolic process|regulation of macrophage activation|xenobiotic metabolic process|muscle cell differentiation|regulation of circadian rhythm|cholesterol homeostasis|regulation of smoothened signaling pathway|cellular response to interleukin-1|nitric oxide biosynthetic process|cerebellar granule cell precursor proliferation|cGMP metabolic process|positive regulation of vascular endothelial growth factor production|triglyceride homeostasis|intracellular receptor signaling pathway|positive regulation of circadian rhythm|oxysterol binding|ligand-activated transcription factor activity|regulation of steroid metabolic process|cellular response to sterol|negative regulation of fat cell differentiation|T-helper 17 cell differentiation|DNA-templated transcription","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|molecular transducer activity|signaling|nucleolus|inflammatory response|anatomical structure development|nucleoplasm|cell differentiation|carbohydrate metabolic process|immune system process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|lipid binding|lipid metabolic process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-597592|R-MMU-383280|R-MMU-4090294|",202956,ENSMUST00000034766,"",regulatory_region_variant,"",tsl1 (assigned to previous version 13),1,"",1,"","","",ENSMUSR00000466281,"","intron_variant|NMD_transcript_variant",9,68690471,MGI:104661,Rora,within coordinates of,SNP,C/T,C,C,T,,"","","","","",""
9,68702580,68702580,1,+,-7.23999977111816,rs33712132,ENSMUSG00000032238,Rora,"increased circulating alkaline phosphatase level|preweaning lethality incomplete penetrance|Purkinje cell degeneration|abnormal Purkinje cell dendrite morphology|abnormal Purkinje cell differentiation|abnormal Purkinje cell morphology|abnormal brain interneuron morphology|abnormal brain morphology|abnormal cerebellar Purkinje cell layer|abnormal cerebellar foliation|abnormal cerebellar granule cell morphology|abnormal cerebellar granule layer morphology|abnormal cerebellar layer morphology|abnormal cerebellar molecular layer|abnormal cerebellum deep nucleus morphology|abnormal cerebellum external granule cell layer morphology|abnormal cerebellum morphology|abnormal cochlear VIII nucleus morphology|abnormal estrous cycle|abnormal excitatory postsynaptic currents|abnormal external female genitalia morphology|abnormal female reproductive system physiology|abnormal fertility/fecundity|abnormal gait|abnormal hormone level|abnormal immune system organ morphology|abnormal immune system physiology|abnormal inferior olivary complex morphology|abnormal limb posture|abnormal lipid homeostasis|abnormal lung compliance|abnormal macrophage physiology|abnormal maternal nurturing|abnormal motor capabilities/coordination/movement|abnormal motor learning|abnormal nervous system physiology|abnormal neuron proliferation|abnormal olfaction|abnormal olfactory bulb external plexiform layer morphology|abnormal olfactory bulb glomerular layer morphology|abnormal olfactory bulb granule cell layer morphology|abnormal olfactory bulb granule cell morphology|abnormal olfactory bulb internal plexiform layer morphology|abnormal olfactory bulb layer morphology|abnormal olfactory bulb mitral cell layer morphology|abnormal olfactory bulb morphology|abnormal olfactory bulb outer nerve layer morphology|abnormal radial glial cell morphology|abnormal respiratory mucosa morphology|abnormal sexual interaction|abnormal spatial learning|abnormal synaptic glutamate release|abnormal vasoconstriction|abnormal vasodilation|absent cerebellar granule cells|absent cerebellar granule layer|absent duvet hair|ataxia|atherosclerotic lesions|decreased Purkinje cell number|decreased aspartic acid level|decreased body size|decreased cerebellar granule cell number|decreased cerebellar granule cell precursor proliferation|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|decreased gamma-aminobutyric acid level|decreased grip strength|decreased locomotor activity|decreased mean systemic arterial blood pressure|decreased taurine level|delaminated Purkinje cell layer|delayed estrous cycle|ectopic Purkinje cell|ectopic cerebellar granule cells|hindlimb paralysis|impaired balance|impaired coordination|impaired limb coordination|impaired righting response|increased IgE level|increased angiogenesis|increased interleukin-1 secretion|increased noradrenaline level|increased susceptibility to atherosclerosis|lethality at weaning incomplete penetrance|limb grasping|lung inflammation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|prolonged estrus|prolonged metestrus|reduced cerebellar foliation|reduced female fertility|retarded hair growth|small cerebellum|small olfactory bulb|sparse hair|spleen atrophy|thin cerebellar granule layer|thin cerebellar molecular layer|thymus atrophy|tremors","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleus|DNA-binding transcription factor activity|sequence-specific DNA binding|nuclear receptor activity|cellular response to hypoxia|nucleolus|positive regulation of transcription by RNA polymerase II|cellular response to tumor necrosis factor|negative regulation of inflammatory response|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of DNA-templated transcription|regulation of gene expression|RNA polymerase II transcription regulatory region sequence-specific DNA binding|rhythmic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleoplasm|beta-catenin binding|circadian regulation of gene expression|transcription coregulator binding|cerebellar Purkinje cell differentiation|transcription coactivator binding|transcription corepressor binding|regulation of glucose metabolic process|regulation of macrophage activation|xenobiotic metabolic process|muscle cell differentiation|regulation of circadian rhythm|cholesterol homeostasis|regulation of smoothened signaling pathway|cellular response to interleukin-1|nitric oxide biosynthetic process|cerebellar granule cell precursor proliferation|cGMP metabolic process|positive regulation of vascular endothelial growth factor production|triglyceride homeostasis|intracellular receptor signaling pathway|positive regulation of circadian rhythm|oxysterol binding|ligand-activated transcription factor activity|regulation of steroid metabolic process|cellular response to sterol|negative regulation of fat cell differentiation|T-helper 17 cell differentiation|DNA-templated transcription","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|molecular transducer activity|signaling|nucleolus|inflammatory response|anatomical structure development|nucleoplasm|cell differentiation|carbohydrate metabolic process|immune system process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|lipid binding|lipid metabolic process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-597592|R-MMU-383280|R-MMU-4090294|",202956,ENSMUST00000034766,"",regulatory_region_variant,TF_binding_site_variant,tsl1 (assigned to previous version 13),1,"",1,"","","ENSPFM0015|ENSPFM0060",ENSMUSR00000751091,"","intron_variant|NMD_transcript_variant",9,68702580,MGI:104661,Rora,within coordinates of,SNP,C/G,G,G,C,,"","","","","",""
9,68798700,68798700,1,+,-5.92999982833862,rs29791749,ENSMUSG00000032238,Rora,"increased circulating alkaline phosphatase level|preweaning lethality incomplete penetrance|Purkinje cell degeneration|abnormal Purkinje cell dendrite morphology|abnormal Purkinje cell differentiation|abnormal Purkinje cell morphology|abnormal brain interneuron morphology|abnormal brain morphology|abnormal cerebellar Purkinje cell layer|abnormal cerebellar foliation|abnormal cerebellar granule cell morphology|abnormal cerebellar granule layer morphology|abnormal cerebellar layer morphology|abnormal cerebellar molecular layer|abnormal cerebellum deep nucleus morphology|abnormal cerebellum external granule cell layer morphology|abnormal cerebellum morphology|abnormal cochlear VIII nucleus morphology|abnormal estrous cycle|abnormal excitatory postsynaptic currents|abnormal external female genitalia morphology|abnormal female reproductive system physiology|abnormal fertility/fecundity|abnormal gait|abnormal hormone level|abnormal immune system organ morphology|abnormal immune system physiology|abnormal inferior olivary complex morphology|abnormal limb posture|abnormal lipid homeostasis|abnormal lung compliance|abnormal macrophage physiology|abnormal maternal nurturing|abnormal motor capabilities/coordination/movement|abnormal motor learning|abnormal nervous system physiology|abnormal neuron proliferation|abnormal olfaction|abnormal olfactory bulb external plexiform layer morphology|abnormal olfactory bulb glomerular layer morphology|abnormal olfactory bulb granule cell layer morphology|abnormal olfactory bulb granule cell morphology|abnormal olfactory bulb internal plexiform layer morphology|abnormal olfactory bulb layer morphology|abnormal olfactory bulb mitral cell layer morphology|abnormal olfactory bulb morphology|abnormal olfactory bulb outer nerve layer morphology|abnormal radial glial cell morphology|abnormal respiratory mucosa morphology|abnormal sexual interaction|abnormal spatial learning|abnormal synaptic glutamate release|abnormal vasoconstriction|abnormal vasodilation|absent cerebellar granule cells|absent cerebellar granule layer|absent duvet hair|ataxia|atherosclerotic lesions|decreased Purkinje cell number|decreased aspartic acid level|decreased body size|decreased cerebellar granule cell number|decreased cerebellar granule cell precursor proliferation|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|decreased gamma-aminobutyric acid level|decreased grip strength|decreased locomotor activity|decreased mean systemic arterial blood pressure|decreased taurine level|delaminated Purkinje cell layer|delayed estrous cycle|ectopic Purkinje cell|ectopic cerebellar granule cells|hindlimb paralysis|impaired balance|impaired coordination|impaired limb coordination|impaired righting response|increased IgE level|increased angiogenesis|increased interleukin-1 secretion|increased noradrenaline level|increased susceptibility to atherosclerosis|lethality at weaning incomplete penetrance|limb grasping|lung inflammation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|prolonged estrus|prolonged metestrus|reduced cerebellar foliation|reduced female fertility|retarded hair growth|small cerebellum|small olfactory bulb|sparse hair|spleen atrophy|thin cerebellar granule layer|thin cerebellar molecular layer|thymus atrophy|tremors","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleus|DNA-binding transcription factor activity|sequence-specific DNA binding|nuclear receptor activity|cellular response to hypoxia|nucleolus|positive regulation of transcription by RNA polymerase II|cellular response to tumor necrosis factor|negative regulation of inflammatory response|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of DNA-templated transcription|regulation of gene expression|RNA polymerase II transcription regulatory region sequence-specific DNA binding|rhythmic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleoplasm|beta-catenin binding|circadian regulation of gene expression|transcription coregulator binding|cerebellar Purkinje cell differentiation|transcription coactivator binding|transcription corepressor binding|regulation of glucose metabolic process|regulation of macrophage activation|xenobiotic metabolic process|muscle cell differentiation|regulation of circadian rhythm|cholesterol homeostasis|regulation of smoothened signaling pathway|cellular response to interleukin-1|nitric oxide biosynthetic process|cerebellar granule cell precursor proliferation|cGMP metabolic process|positive regulation of vascular endothelial growth factor production|triglyceride homeostasis|intracellular receptor signaling pathway|positive regulation of circadian rhythm|oxysterol binding|ligand-activated transcription factor activity|regulation of steroid metabolic process|cellular response to sterol|negative regulation of fat cell differentiation|T-helper 17 cell differentiation|DNA-templated transcription","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|molecular transducer activity|signaling|nucleolus|inflammatory response|anatomical structure development|nucleoplasm|cell differentiation|carbohydrate metabolic process|immune system process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|lipid binding|lipid metabolic process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-597592|R-MMU-383280|R-MMU-4090294|",202956,ENSMUST00000034766,"",regulatory_region_variant,TF_binding_site_variant,tsl1 (assigned to previous version 13),1,"",1,"","","ENSPFM0015|ENSPFM0074|ENSPFM0073",ENSMUSR00000751112,"","intron_variant|NMD_transcript_variant",9,68798700,MGI:104661,Rora,within coordinates of,SNP,A/G,G,G,A,,"","","","","",""
9,69057513,69057513,1,+,-7.65999984741211,rs29591446,ENSMUSG00000032238,Rora,"increased circulating alkaline phosphatase level|preweaning lethality incomplete penetrance|Purkinje cell degeneration|abnormal Purkinje cell dendrite morphology|abnormal Purkinje cell differentiation|abnormal Purkinje cell morphology|abnormal brain interneuron morphology|abnormal brain morphology|abnormal cerebellar Purkinje cell layer|abnormal cerebellar foliation|abnormal cerebellar granule cell morphology|abnormal cerebellar granule layer morphology|abnormal cerebellar layer morphology|abnormal cerebellar molecular layer|abnormal cerebellum deep nucleus morphology|abnormal cerebellum external granule cell layer morphology|abnormal cerebellum morphology|abnormal cochlear VIII nucleus morphology|abnormal estrous cycle|abnormal excitatory postsynaptic currents|abnormal external female genitalia morphology|abnormal female reproductive system physiology|abnormal fertility/fecundity|abnormal gait|abnormal hormone level|abnormal immune system organ morphology|abnormal immune system physiology|abnormal inferior olivary complex morphology|abnormal limb posture|abnormal lipid homeostasis|abnormal lung compliance|abnormal macrophage physiology|abnormal maternal nurturing|abnormal motor capabilities/coordination/movement|abnormal motor learning|abnormal nervous system physiology|abnormal neuron proliferation|abnormal olfaction|abnormal olfactory bulb external plexiform layer morphology|abnormal olfactory bulb glomerular layer morphology|abnormal olfactory bulb granule cell layer morphology|abnormal olfactory bulb granule cell morphology|abnormal olfactory bulb internal plexiform layer morphology|abnormal olfactory bulb layer morphology|abnormal olfactory bulb mitral cell layer morphology|abnormal olfactory bulb morphology|abnormal olfactory bulb outer nerve layer morphology|abnormal radial glial cell morphology|abnormal respiratory mucosa morphology|abnormal sexual interaction|abnormal spatial learning|abnormal synaptic glutamate release|abnormal vasoconstriction|abnormal vasodilation|absent cerebellar granule cells|absent cerebellar granule layer|absent duvet hair|ataxia|atherosclerotic lesions|decreased Purkinje cell number|decreased aspartic acid level|decreased body size|decreased cerebellar granule cell number|decreased cerebellar granule cell precursor proliferation|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|decreased gamma-aminobutyric acid level|decreased grip strength|decreased locomotor activity|decreased mean systemic arterial blood pressure|decreased taurine level|delaminated Purkinje cell layer|delayed estrous cycle|ectopic Purkinje cell|ectopic cerebellar granule cells|hindlimb paralysis|impaired balance|impaired coordination|impaired limb coordination|impaired righting response|increased IgE level|increased angiogenesis|increased interleukin-1 secretion|increased noradrenaline level|increased susceptibility to atherosclerosis|lethality at weaning incomplete penetrance|limb grasping|lung inflammation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|prolonged estrus|prolonged metestrus|reduced cerebellar foliation|reduced female fertility|retarded hair growth|small cerebellum|small olfactory bulb|sparse hair|spleen atrophy|thin cerebellar granule layer|thin cerebellar molecular layer|thymus atrophy|tremors","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleus|DNA-binding transcription factor activity|sequence-specific DNA binding|nuclear receptor activity|cellular response to hypoxia|nucleolus|positive regulation of transcription by RNA polymerase II|cellular response to tumor necrosis factor|negative regulation of inflammatory response|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of DNA-templated transcription|regulation of gene expression|RNA polymerase II transcription regulatory region sequence-specific DNA binding|rhythmic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleoplasm|beta-catenin binding|circadian regulation of gene expression|transcription coregulator binding|cerebellar Purkinje cell differentiation|transcription coactivator binding|transcription corepressor binding|regulation of glucose metabolic process|regulation of macrophage activation|xenobiotic metabolic process|muscle cell differentiation|regulation of circadian rhythm|cholesterol homeostasis|regulation of smoothened signaling pathway|cellular response to interleukin-1|nitric oxide biosynthetic process|cerebellar granule cell precursor proliferation|cGMP metabolic process|positive regulation of vascular endothelial growth factor production|triglyceride homeostasis|intracellular receptor signaling pathway|positive regulation of circadian rhythm|oxysterol binding|ligand-activated transcription factor activity|regulation of steroid metabolic process|cellular response to sterol|negative regulation of fat cell differentiation|T-helper 17 cell differentiation|DNA-templated transcription","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|molecular transducer activity|signaling|nucleolus|inflammatory response|anatomical structure development|nucleoplasm|cell differentiation|carbohydrate metabolic process|immune system process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|lipid binding|lipid metabolic process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-597592|R-MMU-383280|R-MMU-4090294|",202956,ENSMUST00000034766,"",regulatory_region_variant,"",tsl1 (assigned to previous version 13),1,"",1,"","","",ENSMUSR00000277127,"","intron_variant|NMD_transcript_variant",9,69057513,MGI:104661,Rora,within coordinates of,SNP,A/G,A,A,G,,"","","","","",""
9,69237661,69237661,1,+,-5.90000009536743,rs30515807,ENSMUSG00000032238,Rora,"increased circulating alkaline phosphatase level|preweaning lethality incomplete penetrance|Purkinje cell degeneration|abnormal Purkinje cell dendrite morphology|abnormal Purkinje cell differentiation|abnormal Purkinje cell morphology|abnormal brain interneuron morphology|abnormal brain morphology|abnormal cerebellar Purkinje cell layer|abnormal cerebellar foliation|abnormal cerebellar granule cell morphology|abnormal cerebellar granule layer morphology|abnormal cerebellar layer morphology|abnormal cerebellar molecular layer|abnormal cerebellum deep nucleus morphology|abnormal cerebellum external granule cell layer morphology|abnormal cerebellum morphology|abnormal cochlear VIII nucleus morphology|abnormal estrous cycle|abnormal excitatory postsynaptic currents|abnormal external female genitalia morphology|abnormal female reproductive system physiology|abnormal fertility/fecundity|abnormal gait|abnormal hormone level|abnormal immune system organ morphology|abnormal immune system physiology|abnormal inferior olivary complex morphology|abnormal limb posture|abnormal lipid homeostasis|abnormal lung compliance|abnormal macrophage physiology|abnormal maternal nurturing|abnormal motor capabilities/coordination/movement|abnormal motor learning|abnormal nervous system physiology|abnormal neuron proliferation|abnormal olfaction|abnormal olfactory bulb external plexiform layer morphology|abnormal olfactory bulb glomerular layer morphology|abnormal olfactory bulb granule cell layer morphology|abnormal olfactory bulb granule cell morphology|abnormal olfactory bulb internal plexiform layer morphology|abnormal olfactory bulb layer morphology|abnormal olfactory bulb mitral cell layer morphology|abnormal olfactory bulb morphology|abnormal olfactory bulb outer nerve layer morphology|abnormal radial glial cell morphology|abnormal respiratory mucosa morphology|abnormal sexual interaction|abnormal spatial learning|abnormal synaptic glutamate release|abnormal vasoconstriction|abnormal vasodilation|absent cerebellar granule cells|absent cerebellar granule layer|absent duvet hair|ataxia|atherosclerotic lesions|decreased Purkinje cell number|decreased aspartic acid level|decreased body size|decreased cerebellar granule cell number|decreased cerebellar granule cell precursor proliferation|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|decreased gamma-aminobutyric acid level|decreased grip strength|decreased locomotor activity|decreased mean systemic arterial blood pressure|decreased taurine level|delaminated Purkinje cell layer|delayed estrous cycle|ectopic Purkinje cell|ectopic cerebellar granule cells|hindlimb paralysis|impaired balance|impaired coordination|impaired limb coordination|impaired righting response|increased IgE level|increased angiogenesis|increased interleukin-1 secretion|increased noradrenaline level|increased susceptibility to atherosclerosis|lethality at weaning incomplete penetrance|limb grasping|lung inflammation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|prolonged estrus|prolonged metestrus|reduced cerebellar foliation|reduced female fertility|retarded hair growth|small cerebellum|small olfactory bulb|sparse hair|spleen atrophy|thin cerebellar granule layer|thin cerebellar molecular layer|thymus atrophy|tremors","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleus|DNA-binding transcription factor activity|sequence-specific DNA binding|nuclear receptor activity|cellular response to hypoxia|nucleolus|positive regulation of transcription by RNA polymerase II|cellular response to tumor necrosis factor|negative regulation of inflammatory response|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of DNA-templated transcription|regulation of gene expression|RNA polymerase II transcription regulatory region sequence-specific DNA binding|rhythmic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleoplasm|beta-catenin binding|circadian regulation of gene expression|transcription coregulator binding|cerebellar Purkinje cell differentiation|transcription coactivator binding|transcription corepressor binding|regulation of glucose metabolic process|regulation of macrophage activation|xenobiotic metabolic process|muscle cell differentiation|regulation of circadian rhythm|cholesterol homeostasis|regulation of smoothened signaling pathway|cellular response to interleukin-1|nitric oxide biosynthetic process|cerebellar granule cell precursor proliferation|cGMP metabolic process|positive regulation of vascular endothelial growth factor production|triglyceride homeostasis|intracellular receptor signaling pathway|positive regulation of circadian rhythm|oxysterol binding|ligand-activated transcription factor activity|regulation of steroid metabolic process|cellular response to sterol|negative regulation of fat cell differentiation|T-helper 17 cell differentiation|DNA-templated transcription","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|molecular transducer activity|signaling|nucleolus|inflammatory response|anatomical structure development|nucleoplasm|cell differentiation|carbohydrate metabolic process|immune system process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|lipid binding|lipid metabolic process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-597592|R-MMU-383280|R-MMU-4090294|",202956,"ENSMUST00000034766|ENSMUST00000113624","",regulatory_region_variant,"","tsl1 (assigned to previous version 13)|tsl1 (assigned to previous version 2)",1,"|principal1",1,"","","",ENSMUSR00000875532,"","intron_variant|NMD_transcript_variant",9,69237661,MGI:104661,Rora,within coordinates of,SNP,A/G,A,A,G,,"","","","","",""
9,69241099,69241099,1,+,-5.17999982833862,rs3708799,ENSMUSG00000032238,Rora,"increased circulating alkaline phosphatase level|preweaning lethality incomplete penetrance|Purkinje cell degeneration|abnormal Purkinje cell dendrite morphology|abnormal Purkinje cell differentiation|abnormal Purkinje cell morphology|abnormal brain interneuron morphology|abnormal brain morphology|abnormal cerebellar Purkinje cell layer|abnormal cerebellar foliation|abnormal cerebellar granule cell morphology|abnormal cerebellar granule layer morphology|abnormal cerebellar layer morphology|abnormal cerebellar molecular layer|abnormal cerebellum deep nucleus morphology|abnormal cerebellum external granule cell layer morphology|abnormal cerebellum morphology|abnormal cochlear VIII nucleus morphology|abnormal estrous cycle|abnormal excitatory postsynaptic currents|abnormal external female genitalia morphology|abnormal female reproductive system physiology|abnormal fertility/fecundity|abnormal gait|abnormal hormone level|abnormal immune system organ morphology|abnormal immune system physiology|abnormal inferior olivary complex morphology|abnormal limb posture|abnormal lipid homeostasis|abnormal lung compliance|abnormal macrophage physiology|abnormal maternal nurturing|abnormal motor capabilities/coordination/movement|abnormal motor learning|abnormal nervous system physiology|abnormal neuron proliferation|abnormal olfaction|abnormal olfactory bulb external plexiform layer morphology|abnormal olfactory bulb glomerular layer morphology|abnormal olfactory bulb granule cell layer morphology|abnormal olfactory bulb granule cell morphology|abnormal olfactory bulb internal plexiform layer morphology|abnormal olfactory bulb layer morphology|abnormal olfactory bulb mitral cell layer morphology|abnormal olfactory bulb morphology|abnormal olfactory bulb outer nerve layer morphology|abnormal radial glial cell morphology|abnormal respiratory mucosa morphology|abnormal sexual interaction|abnormal spatial learning|abnormal synaptic glutamate release|abnormal vasoconstriction|abnormal vasodilation|absent cerebellar granule cells|absent cerebellar granule layer|absent duvet hair|ataxia|atherosclerotic lesions|decreased Purkinje cell number|decreased aspartic acid level|decreased body size|decreased cerebellar granule cell number|decreased cerebellar granule cell precursor proliferation|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|decreased gamma-aminobutyric acid level|decreased grip strength|decreased locomotor activity|decreased mean systemic arterial blood pressure|decreased taurine level|delaminated Purkinje cell layer|delayed estrous cycle|ectopic Purkinje cell|ectopic cerebellar granule cells|hindlimb paralysis|impaired balance|impaired coordination|impaired limb coordination|impaired righting response|increased IgE level|increased angiogenesis|increased interleukin-1 secretion|increased noradrenaline level|increased susceptibility to atherosclerosis|lethality at weaning incomplete penetrance|limb grasping|lung inflammation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|prolonged estrus|prolonged metestrus|reduced cerebellar foliation|reduced female fertility|retarded hair growth|small cerebellum|small olfactory bulb|sparse hair|spleen atrophy|thin cerebellar granule layer|thin cerebellar molecular layer|thymus atrophy|tremors","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleus|DNA-binding transcription factor activity|sequence-specific DNA binding|nuclear receptor activity|cellular response to hypoxia|nucleolus|positive regulation of transcription by RNA polymerase II|cellular response to tumor necrosis factor|negative regulation of inflammatory response|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of DNA-templated transcription|regulation of gene expression|RNA polymerase II transcription regulatory region sequence-specific DNA binding|rhythmic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleoplasm|beta-catenin binding|circadian regulation of gene expression|transcription coregulator binding|cerebellar Purkinje cell differentiation|transcription coactivator binding|transcription corepressor binding|regulation of glucose metabolic process|regulation of macrophage activation|xenobiotic metabolic process|muscle cell differentiation|regulation of circadian rhythm|cholesterol homeostasis|regulation of smoothened signaling pathway|cellular response to interleukin-1|nitric oxide biosynthetic process|cerebellar granule cell precursor proliferation|cGMP metabolic process|positive regulation of vascular endothelial growth factor production|triglyceride homeostasis|intracellular receptor signaling pathway|positive regulation of circadian rhythm|oxysterol binding|ligand-activated transcription factor activity|regulation of steroid metabolic process|cellular response to sterol|negative regulation of fat cell differentiation|T-helper 17 cell differentiation|DNA-templated transcription","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|molecular transducer activity|signaling|nucleolus|inflammatory response|anatomical structure development|nucleoplasm|cell differentiation|carbohydrate metabolic process|immune system process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|lipid binding|lipid metabolic process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-597592|R-MMU-383280|R-MMU-4090294|",202956,"ENSMUST00000034766|ENSMUST00000113624","",regulatory_region_variant,"","tsl1 (assigned to previous version 13)|tsl1 (assigned to previous version 2)",1,"|principal1",1,"","","",ENSMUSR00000466384,"","intron_variant|NMD_transcript_variant",9,69241099,MGI:104661,Rora,within coordinates of,SNP,C/T,T,"",C,,"","","","","",""
9,69271503,69271503,1,+,-7.32000017166138,rs4227738,ENSMUSG00000032238,Rora,"increased circulating alkaline phosphatase level|preweaning lethality incomplete penetrance|Purkinje cell degeneration|abnormal Purkinje cell dendrite morphology|abnormal Purkinje cell differentiation|abnormal Purkinje cell morphology|abnormal brain interneuron morphology|abnormal brain morphology|abnormal cerebellar Purkinje cell layer|abnormal cerebellar foliation|abnormal cerebellar granule cell morphology|abnormal cerebellar granule layer morphology|abnormal cerebellar layer morphology|abnormal cerebellar molecular layer|abnormal cerebellum deep nucleus morphology|abnormal cerebellum external granule cell layer morphology|abnormal cerebellum morphology|abnormal cochlear VIII nucleus morphology|abnormal estrous cycle|abnormal excitatory postsynaptic currents|abnormal external female genitalia morphology|abnormal female reproductive system physiology|abnormal fertility/fecundity|abnormal gait|abnormal hormone level|abnormal immune system organ morphology|abnormal immune system physiology|abnormal inferior olivary complex morphology|abnormal limb posture|abnormal lipid homeostasis|abnormal lung compliance|abnormal macrophage physiology|abnormal maternal nurturing|abnormal motor capabilities/coordination/movement|abnormal motor learning|abnormal nervous system physiology|abnormal neuron proliferation|abnormal olfaction|abnormal olfactory bulb external plexiform layer morphology|abnormal olfactory bulb glomerular layer morphology|abnormal olfactory bulb granule cell layer morphology|abnormal olfactory bulb granule cell morphology|abnormal olfactory bulb internal plexiform layer morphology|abnormal olfactory bulb layer morphology|abnormal olfactory bulb mitral cell layer morphology|abnormal olfactory bulb morphology|abnormal olfactory bulb outer nerve layer morphology|abnormal radial glial cell morphology|abnormal respiratory mucosa morphology|abnormal sexual interaction|abnormal spatial learning|abnormal synaptic glutamate release|abnormal vasoconstriction|abnormal vasodilation|absent cerebellar granule cells|absent cerebellar granule layer|absent duvet hair|ataxia|atherosclerotic lesions|decreased Purkinje cell number|decreased aspartic acid level|decreased body size|decreased cerebellar granule cell number|decreased cerebellar granule cell precursor proliferation|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|decreased gamma-aminobutyric acid level|decreased grip strength|decreased locomotor activity|decreased mean systemic arterial blood pressure|decreased taurine level|delaminated Purkinje cell layer|delayed estrous cycle|ectopic Purkinje cell|ectopic cerebellar granule cells|hindlimb paralysis|impaired balance|impaired coordination|impaired limb coordination|impaired righting response|increased IgE level|increased angiogenesis|increased interleukin-1 secretion|increased noradrenaline level|increased susceptibility to atherosclerosis|lethality at weaning incomplete penetrance|limb grasping|lung inflammation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|prolonged estrus|prolonged metestrus|reduced cerebellar foliation|reduced female fertility|retarded hair growth|small cerebellum|small olfactory bulb|sparse hair|spleen atrophy|thin cerebellar granule layer|thin cerebellar molecular layer|thymus atrophy|tremors","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleus|DNA-binding transcription factor activity|sequence-specific DNA binding|nuclear receptor activity|cellular response to hypoxia|nucleolus|positive regulation of transcription by RNA polymerase II|cellular response to tumor necrosis factor|negative regulation of inflammatory response|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of DNA-templated transcription|regulation of gene expression|RNA polymerase II transcription regulatory region sequence-specific DNA binding|rhythmic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleoplasm|beta-catenin binding|circadian regulation of gene expression|transcription coregulator binding|cerebellar Purkinje cell differentiation|transcription coactivator binding|transcription corepressor binding|regulation of glucose metabolic process|regulation of macrophage activation|xenobiotic metabolic process|muscle cell differentiation|regulation of circadian rhythm|cholesterol homeostasis|regulation of smoothened signaling pathway|cellular response to interleukin-1|nitric oxide biosynthetic process|cerebellar granule cell precursor proliferation|cGMP metabolic process|positive regulation of vascular endothelial growth factor production|triglyceride homeostasis|intracellular receptor signaling pathway|positive regulation of circadian rhythm|oxysterol binding|ligand-activated transcription factor activity|regulation of steroid metabolic process|cellular response to sterol|negative regulation of fat cell differentiation|T-helper 17 cell differentiation|DNA-templated transcription","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|molecular transducer activity|signaling|nucleolus|inflammatory response|anatomical structure development|nucleoplasm|cell differentiation|carbohydrate metabolic process|immune system process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|lipid binding|lipid metabolic process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-597592|R-MMU-383280|R-MMU-4090294|",202956,"ENSMUST00000034766|ENSMUST00000113624","",regulatory_region_variant,"","tsl1 (assigned to previous version 13)|tsl1 (assigned to previous version 2)",1,"|principal1",1,"","V|","",ENSMUSR00000751194,"","synonymous_variant|3_prime_UTR_variant|NMD_transcript_variant",9,69271503,MGI:104661,Rora,within coordinates of,SNP,C/T,T,T,C,,"",T,"",T,"",""
9,69278864,69278864,1,+,-7.55999994277954,rs16817651,ENSMUSG00000032238,Rora,"increased circulating alkaline phosphatase level|preweaning lethality incomplete penetrance|Purkinje cell degeneration|abnormal Purkinje cell dendrite morphology|abnormal Purkinje cell differentiation|abnormal Purkinje cell morphology|abnormal brain interneuron morphology|abnormal brain morphology|abnormal cerebellar Purkinje cell layer|abnormal cerebellar foliation|abnormal cerebellar granule cell morphology|abnormal cerebellar granule layer morphology|abnormal cerebellar layer morphology|abnormal cerebellar molecular layer|abnormal cerebellum deep nucleus morphology|abnormal cerebellum external granule cell layer morphology|abnormal cerebellum morphology|abnormal cochlear VIII nucleus morphology|abnormal estrous cycle|abnormal excitatory postsynaptic currents|abnormal external female genitalia morphology|abnormal female reproductive system physiology|abnormal fertility/fecundity|abnormal gait|abnormal hormone level|abnormal immune system organ morphology|abnormal immune system physiology|abnormal inferior olivary complex morphology|abnormal limb posture|abnormal lipid homeostasis|abnormal lung compliance|abnormal macrophage physiology|abnormal maternal nurturing|abnormal motor capabilities/coordination/movement|abnormal motor learning|abnormal nervous system physiology|abnormal neuron proliferation|abnormal olfaction|abnormal olfactory bulb external plexiform layer morphology|abnormal olfactory bulb glomerular layer morphology|abnormal olfactory bulb granule cell layer morphology|abnormal olfactory bulb granule cell morphology|abnormal olfactory bulb internal plexiform layer morphology|abnormal olfactory bulb layer morphology|abnormal olfactory bulb mitral cell layer morphology|abnormal olfactory bulb morphology|abnormal olfactory bulb outer nerve layer morphology|abnormal radial glial cell morphology|abnormal respiratory mucosa morphology|abnormal sexual interaction|abnormal spatial learning|abnormal synaptic glutamate release|abnormal vasoconstriction|abnormal vasodilation|absent cerebellar granule cells|absent cerebellar granule layer|absent duvet hair|ataxia|atherosclerotic lesions|decreased Purkinje cell number|decreased aspartic acid level|decreased body size|decreased cerebellar granule cell number|decreased cerebellar granule cell precursor proliferation|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|decreased gamma-aminobutyric acid level|decreased grip strength|decreased locomotor activity|decreased mean systemic arterial blood pressure|decreased taurine level|delaminated Purkinje cell layer|delayed estrous cycle|ectopic Purkinje cell|ectopic cerebellar granule cells|hindlimb paralysis|impaired balance|impaired coordination|impaired limb coordination|impaired righting response|increased IgE level|increased angiogenesis|increased interleukin-1 secretion|increased noradrenaline level|increased susceptibility to atherosclerosis|lethality at weaning incomplete penetrance|limb grasping|lung inflammation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|prolonged estrus|prolonged metestrus|reduced cerebellar foliation|reduced female fertility|retarded hair growth|small cerebellum|small olfactory bulb|sparse hair|spleen atrophy|thin cerebellar granule layer|thin cerebellar molecular layer|thymus atrophy|tremors","DNA binding|zinc ion binding|regulation of DNA-templated transcription|nucleus|DNA-binding transcription factor activity|sequence-specific DNA binding|nuclear receptor activity|cellular response to hypoxia|nucleolus|positive regulation of transcription by RNA polymerase II|cellular response to tumor necrosis factor|negative regulation of inflammatory response|RNA polymerase II cis-regulatory region sequence-specific DNA binding|angiogenesis|metal ion binding|regulation of transcription by RNA polymerase II|DNA-binding transcription factor activity, RNA polymerase II-specific|protein binding|positive regulation of DNA-templated transcription|regulation of gene expression|RNA polymerase II transcription regulatory region sequence-specific DNA binding|rhythmic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleoplasm|beta-catenin binding|circadian regulation of gene expression|transcription coregulator binding|cerebellar Purkinje cell differentiation|transcription coactivator binding|transcription corepressor binding|regulation of glucose metabolic process|regulation of macrophage activation|xenobiotic metabolic process|muscle cell differentiation|regulation of circadian rhythm|cholesterol homeostasis|regulation of smoothened signaling pathway|cellular response to interleukin-1|nitric oxide biosynthetic process|cerebellar granule cell precursor proliferation|cGMP metabolic process|positive regulation of vascular endothelial growth factor production|triglyceride homeostasis|intracellular receptor signaling pathway|positive regulation of circadian rhythm|oxysterol binding|ligand-activated transcription factor activity|regulation of steroid metabolic process|cellular response to sterol|negative regulation of fat cell differentiation|T-helper 17 cell differentiation|DNA-templated transcription","DNA binding|DNA-templated transcription|regulation of DNA-templated transcription|organelle|nucleus|transcription regulator activity|molecular transducer activity|signaling|nucleolus|inflammatory response|anatomical structure development|nucleoplasm|cell differentiation|carbohydrate metabolic process|immune system process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|lipid binding|lipid metabolic process","R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-392499|R-MMU-2990846|R-MMU-3108232|R-MMU-597592|R-MMU-383280|R-MMU-4090294|",202956,"ENSMUST00000034766|ENSMUST00000113624","",regulatory_region_variant,TF_binding_site_variant,"tsl1 (assigned to previous version 13)|tsl1 (assigned to previous version 2)",1,"|principal1",1,"","",ENSPFM0002,ENSMUSR00000875535,"",intron_variant,9,69278864,MGI:104661,Rora,within coordinates of,SNP,C/T,T,T,C,,"",T,"",T,"",""
9,71858362,71858362,1,+,-5.44999980926514,rs6283705,ENSMUSG00000032228,Tcf12,"abnormal B cell differentiation|abnormal B cell morphology|abnormal T cell differentiation|abnormal T cell morphology|abnormal response to transplant|absent T cells|arrested T cell differentiation|decreased B cell number|decreased CD4-positive alpha beta T cell number|decreased double-positive T cell number|decreased immature B cell number|decreased pre-B cell number|decreased pro-B cell number|decreased thymocyte number|exencephaly|increased CD8-positive alpha-beta T cell number|increased double-negative T cell number|increased effector memory CD4-positive alpha-beta T cell number|postnatal growth retardation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|seizures|thymus hypoplasia","protein dimerization activity|nucleus|nuclear speck|protein binding|positive regulation of gene expression|positive regulation of transcription by RNA polymerase II|gene expression|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cytoplasm|transcription cis-regulatory region binding|chromatin|nucleoplasm|DNA binding|regulation of transcription by RNA polymerase II|nervous system development|DNA-binding transcription factor activity, RNA polymerase II-specific|intracellular membrane-bounded organelle|DNA-binding transcription factor activity|cell differentiation|positive regulation of DNA-templated transcription|DNA-binding transcription activator activity, RNA polymerase II-specific|protein heterodimerization activity|sequence-specific double-stranded DNA binding|transcription regulator complex|RNA polymerase II transcription regulator complex|DNA-binding transcription factor binding|SMAD binding|bHLH transcription factor binding|E-box binding|positive regulation of neuron differentiation|HMG box domain binding|cAMP response element binding|response to gonadotropin-releasing hormone","organelle|nucleus|nucleoplasm|DNA-templated transcription|regulation of DNA-templated transcription|DNA binding|chromosome|anatomical structure development|transcription regulator activity|cell differentiation","R-MMU-1266738|R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-8878171|R-MMU-525793|R-MMU-8939236|",204000,"ENSMUST00000183404|ENSMUST00000183992|ENSMUST00000184867","",regulatory_region_variant,"",tsl1 (assigned to previous version 7),1,"principal4|",-1,"","","",ENSMUSR00000277723,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant",9,71858362,MGI:101877,Tcf12,within coordinates of,SNP,G/T,T,T,G,,"","","","","",
9,71943027,71943027,1,+,-5.73999977111816,rs29639464,ENSMUSG00000032228|ENSMUSG00000102874|ENSMUSG00002076016,Tcf12|Gm37137|Gm56062,"abnormal B cell differentiation|abnormal B cell morphology|abnormal T cell differentiation|abnormal T cell morphology|abnormal response to transplant|absent T cells|arrested T cell differentiation|decreased B cell number|decreased CD4-positive alpha beta T cell number|decreased double-positive T cell number|decreased immature B cell number|decreased pre-B cell number|decreased pro-B cell number|decreased thymocyte number|exencephaly|increased CD8-positive alpha-beta T cell number|increased double-negative T cell number|increased effector memory CD4-positive alpha-beta T cell number|postnatal growth retardation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|seizures|thymus hypoplasia"|"","protein dimerization activity|nucleus|nuclear speck|protein binding|positive regulation of gene expression|positive regulation of transcription by RNA polymerase II|gene expression|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cytoplasm|transcription cis-regulatory region binding|chromatin|nucleoplasm|DNA binding|regulation of transcription by RNA polymerase II|nervous system development|DNA-binding transcription factor activity, RNA polymerase II-specific|intracellular membrane-bounded organelle|DNA-binding transcription factor activity|cell differentiation|positive regulation of DNA-templated transcription|DNA-binding transcription activator activity, RNA polymerase II-specific|protein heterodimerization activity|sequence-specific double-stranded DNA binding|transcription regulator complex|RNA polymerase II transcription regulator complex|DNA-binding transcription factor binding|SMAD binding|bHLH transcription factor binding|E-box binding|positive regulation of neuron differentiation|HMG box domain binding|cAMP response element binding|response to gonadotropin-releasing hormone"|"","organelle|nucleus|nucleoplasm|DNA-templated transcription|regulation of DNA-templated transcription|DNA binding|chromosome|anatomical structure development|transcription regulator activity|cell differentiation"|"","R-MMU-1266738|R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-8878171|R-MMU-525793|R-MMU-8939236|"|"",204000|"","ENSMUST00000183404|ENSMUST00000183992|ENSMUST00000184867"|"","",regulatory_region_variant|"","",tsl1 (assigned to previous version 7)|"",1|"","principal4|"|"",-1|1,"","","",ENSMUSR00000277753,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant"|downstream_gene_variant,9,71943027,MGI:101877,Tcf12,within coordinates of,SNP,A/G,G,G,A,,"","","","","",
9,71946021,71946021,1,+,-5.36999988555908,rs30334890,ENSMUSG00000032228|ENSMUSG00000102874,Tcf12|Gm37137,"abnormal B cell differentiation|abnormal B cell morphology|abnormal T cell differentiation|abnormal T cell morphology|abnormal response to transplant|absent T cells|arrested T cell differentiation|decreased B cell number|decreased CD4-positive alpha beta T cell number|decreased double-positive T cell number|decreased immature B cell number|decreased pre-B cell number|decreased pro-B cell number|decreased thymocyte number|exencephaly|increased CD8-positive alpha-beta T cell number|increased double-negative T cell number|increased effector memory CD4-positive alpha-beta T cell number|postnatal growth retardation|postnatal lethality complete penetrance|postnatal lethality incomplete penetrance|seizures|thymus hypoplasia"|"","protein dimerization activity|nucleus|nuclear speck|protein binding|positive regulation of gene expression|positive regulation of transcription by RNA polymerase II|gene expression|RNA polymerase II cis-regulatory region sequence-specific DNA binding|cytoplasm|transcription cis-regulatory region binding|chromatin|nucleoplasm|DNA binding|regulation of transcription by RNA polymerase II|nervous system development|DNA-binding transcription factor activity, RNA polymerase II-specific|intracellular membrane-bounded organelle|DNA-binding transcription factor activity|cell differentiation|positive regulation of DNA-templated transcription|DNA-binding transcription activator activity, RNA polymerase II-specific|protein heterodimerization activity|sequence-specific double-stranded DNA binding|transcription regulator complex|RNA polymerase II transcription regulator complex|DNA-binding transcription factor binding|SMAD binding|bHLH transcription factor binding|E-box binding|positive regulation of neuron differentiation|HMG box domain binding|cAMP response element binding|response to gonadotropin-releasing hormone"|"","organelle|nucleus|nucleoplasm|DNA-templated transcription|regulation of DNA-templated transcription|DNA binding|chromosome|anatomical structure development|transcription regulator activity|cell differentiation"|"","R-MMU-1266738|R-MMU-212436|R-MMU-73857|R-MMU-74160|R-MMU-8878171|R-MMU-525793|R-MMU-8939236|"|"",204000|"","ENSMUST00000183404|ENSMUST00000183992|ENSMUST00000184867"|"","",regulatory_region_variant|"","",tsl1 (assigned to previous version 7)|"",1|"","principal4|"|"",-1,"","","",ENSMUSR00000277753,"","intron_variant|NMD_transcript_variant|non_coding_transcript_variant"|downstream_gene_variant,9,71946021,MGI:101877,Tcf12,within coordinates of,SNP,A/G,G,G,A,,"","","","","",
